Overview of nano-drugs characteristics for clinical application: the journey from the entry to the exit point

The ever-increasing number of diseases worldwide requires comprehensive, efficient, and cost-effective modes of treatments. Among various strategies, nanomaterials fulfill most of these criteria. The unique physicochemical properties of nanoparticles have made them a premier choice as a drug or a dr...

Full description

Saved in:
Bibliographic Details
Published inJournal of nanoparticle research : an interdisciplinary forum for nanoscale science and technology Vol. 16; no. 8; pp. 1 - 25
Main Authors Bose, Tanima, Latawiec, Diane, Mondal, Partha Pratim, Mandal, Subhra
Format Journal Article
LanguageEnglish
Published Dordrecht Springer Netherlands 01.08.2014
Springer
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The ever-increasing number of diseases worldwide requires comprehensive, efficient, and cost-effective modes of treatments. Among various strategies, nanomaterials fulfill most of these criteria. The unique physicochemical properties of nanoparticles have made them a premier choice as a drug or a drug delivery system for the purpose of treatment, and as bio-detectors for disease prognosis. However, the main challenge is the proper consideration of the physical properties of these nanomaterials, while developing them as potential tools for therapeutics and/or diagnostics. In this review, we focus mainly on the characteristics of nanoparticles to develop an effective and sensitive system for clinical purposes. This review will present an overview of the important properties of nanoparticles, through their journey from its route of administration until disposal from the human body after accomplishing targeted functionality. We have chosen cancer as our model disease to explain the potentiality of nano-systems for therapeutics and diagnostics in relation to several organs (intestine, lung, brain, etc.). Furthermore, we have discussed their biodegradability and accumulation probability which can cause unfavorable side effects in healthy human subjects.
AbstractList The ever-increasing number of diseases worldwide requires comprehensive, efficient, and cost-effective modes of treatments. Among various strategies, nanomaterials fulfill most of these criteria. The unique physicochemical properties of nanoparticles have made them a premier choice as a drug or a drug delivery system for the purpose of treatment, and as bio-detectors for disease prognosis. However, the main challenge is the proper consideration of the physical properties of these nanomaterials, while developing them as potential tools for therapeutics and/or diagnostics. In this review, we focus mainly on the characteristics of nanoparticles to develop an effective and sensitive system for clinical purposes. This review will present an overview of the important properties of nanoparticles, through their journey from its route of administration until disposal from the human body after accomplishing targeted functionality. We have chosen cancer as our model disease to explain the potentiality of nano-systems for therapeutics and diagnostics in relation to several organs (intestine, lung, brain, etc.). Furthermore, we have discussed their biodegradability and accumulation probability which can cause unfavorable side effects in healthy human subjects.[PUBLICATION ABSTRACT]
The ever-increasing number of diseases worldwide requires comprehensive, efficient, and cost-effective modes of treatments. Among various strategies, nanomaterials fulfill most of these criteria. The unique physicochemical properties of nanoparticles have made them a premier choice as a drug or a drug delivery system for the purpose of treatment, and as bio-detectors for disease prognosis. However, the main challenge is the proper consideration of the physical properties of these nanomaterials, while developing them as potential tools for therapeutics and/or diagnostics. In this review, we focus mainly on the characteristics of nanoparticles to develop an effective and sensitive system for clinical purposes. This review will present an overview of the important properties of nanoparticles, through their journey from its route of administration until disposal from the human body after accomplishing targeted functionality. We have chosen cancer as our model disease to explain the potentiality of nano-systems for therapeutics and diagnostics in relation to several organs (intestine, lung, brain, etc.). Furthermore, we have discussed their biodegradability and accumulation probability which can cause unfavorable side effects in healthy human subjects.
ArticleNumber 2527
Author Mondal, Partha Pratim
Mandal, Subhra
Latawiec, Diane
Bose, Tanima
Author_xml – sequence: 1
  givenname: Tanima
  surname: Bose
  fullname: Bose, Tanima
  organization: Leibniz Institute for Neurobiology
– sequence: 2
  givenname: Diane
  surname: Latawiec
  fullname: Latawiec, Diane
  organization: NIHR Liverpool Pancreas Biomedical Research Unit, Department of Molecular and Clinical Cancer Medicine, University of Liverpool
– sequence: 3
  givenname: Partha Pratim
  surname: Mondal
  fullname: Mondal, Partha Pratim
  organization: Nanobioimaging Laboratory, Indian Institute of Science
– sequence: 4
  givenname: Subhra
  surname: Mandal
  fullname: Mandal, Subhra
  email: subhramandal@gmail.com
  organization: Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28734207$$DView record in Pascal Francis
BookMark eNp9kV1LBSEQhiUK-vwB3QkRdGOpu65udxF9QdBNQXfiulrGHt3UU51_n-dsRAR15eg87zgz7zZY98EbAPYJPiYY85NECGYEYVIjyihHfA1sEcYpEm3zuF7iSgiEeVNvgu2UXjAmDW3pFpjdvZn45sw7DBZ65QPq4_wpQf2sotLZRJey0wnaEKEenHdaDVCN41CC7II_hfnZwJcwj94soI1htnowPscFzGG6fLgMx-B83gUbVg3J7H2dO-Dh8uL-_Brd3l3dnJ_dIl3XLKOmFbwnzLadYXVXs453dd_bFmvbMWFKxjLLmeakU7zSquubSjBlaUcpbZiodsDRVHeM4XVuUpYzl7QZBuVNmCdJWMOxIITTgh78QlfDlO4KxWgBG7wsePhFqVQ2YKPy2iU5RjdTcSGp4FVNMS8cmTgdQ0rR2G-EYLk0Sk5GyWKUXBollxr-S6NdXi03R-WGf5V0Uqbyi38y8Ufvf4o-AdasqjE
CitedBy_id crossref_primary_10_1016_j_mtbio_2022_100228
crossref_primary_10_1039_D2MA00536K
crossref_primary_10_1016_j_bcab_2022_102440
crossref_primary_10_2147_IJN_S276033
crossref_primary_10_1109_TMAG_2024_3406960
crossref_primary_10_1016_j_antiviral_2019_04_010
crossref_primary_10_1186_s12951_024_02433_4
crossref_primary_10_1021_acsami_0c13865
crossref_primary_10_1016_j_biomaterials_2022_121533
crossref_primary_10_1016_j_antiviral_2019_04_007
crossref_primary_10_1021_acsanm_2c01665
crossref_primary_10_1515_ntrev_2022_0148
crossref_primary_10_3390_nano6040066
crossref_primary_10_1007_s13346_020_00750_3
crossref_primary_10_1021_acsanm_3c04935
crossref_primary_10_1186_s11671_024_04002_y
crossref_primary_10_1002_adtp_201900123
crossref_primary_10_1080_00914037_2022_2097680
crossref_primary_10_1128_AAC_00450_16
crossref_primary_10_21926_obm_neurobiol_2401208
crossref_primary_10_1063_1_4926584
crossref_primary_10_1080_17435390_2023_2187322
crossref_primary_10_1002_adma_201808166
crossref_primary_10_1039_C6TB00308G
crossref_primary_10_1128_AAC_01475_16
crossref_primary_10_3390_cancers13040898
crossref_primary_10_3390_molecules28062738
crossref_primary_10_1007_s00396_015_3767_5
crossref_primary_10_1021_acsabm_3c00595
crossref_primary_10_1002_iub_2105
crossref_primary_10_1007_s11051_020_04992_7
crossref_primary_10_1021_acs_chemmater_2c00498
crossref_primary_10_1002_adfm_201601369
crossref_primary_10_1021_acs_langmuir_7b02354
crossref_primary_10_2147_IJN_S331060
crossref_primary_10_1039_C4FD00199K
crossref_primary_10_1016_j_ijpharm_2024_124799
crossref_primary_10_1002_wnan_1808
crossref_primary_10_1016_j_addr_2023_114898
crossref_primary_10_1016_j_pmatsci_2022_101014
crossref_primary_10_1039_C8RA02899K
crossref_primary_10_1016_j_actbio_2020_03_013
crossref_primary_10_1016_j_antiviral_2018_06_005
crossref_primary_10_1128_AAC_02320_20
crossref_primary_10_26599_NBE_2024_9290086
crossref_primary_10_1002_cjce_23048
crossref_primary_10_1021_acsnano_8b03726
crossref_primary_10_1007_s11051_018_4291_6
Cites_doi 10.1002/smll.201100442
10.1016/j.copbio.2007.01.003
10.3390/molecules18078440
10.1038/sj.bjp.0707130
10.3727/000000006783980937
10.1166/jctn.2009.1189
10.1039/b701744h
10.1177/117739280700200002
10.1007/s12272-011-0220-2
10.1038/sj.mt.6300306
10.1016/j.tibtech.2011.06.010
10.1021/la0531998
10.1080/10717540802321495
10.1080/02688690701765524
10.1016/j.nano.2008.11.002
10.1021/ar2003336
10.1016/j.jconrel.2012.10.007
10.1021/nn901025x
10.1021/nn406590q
10.1093/toxsci/kfm243
10.1186/1743-8977-7-39
10.3390/ijms12074591
10.1124/dmd.112.044925
10.1038/cgt.2013.9
10.1021/mp800051m
10.1016/j.jconrel.2004.04.026
10.1002/cbdv.200900021
10.1016/j.tube.2004.11.003
10.1016/j.ijpharm.2007.11.037
10.1016/j.progpolymsci.2007.09.003
10.2147/nano.2006.1.4.375
10.1186/1743-8977-4-10
10.2174/0929867311320170006
10.1016/S1734-1140(12)70901-5
10.1038/nbt.1504
10.1016/j.biomaterials.2006.01.038
10.1208/aapsj0902015
10.1002/jps.23463
10.1002/adma.201100140
10.1016/j.addr.2005.09.018
10.1371/journal.pone.0063159
10.1039/c2cs15344k
10.1038/nature08956
10.1016/j.biomaterials.2011.11.081
10.1093/toxsci/kfn245
10.1016/j.biomaterials.2010.05.007
10.1016/j.addr.2013.11.009
10.1016/j.addr.2008.11.002
10.1021/la703570m
10.1016/j.ijpharm.2009.01.014
10.1016/j.addr.2008.03.012
10.1146/annurev-med-070910-083323
10.1038/mt.2008.127
10.1016/j.ijpharm.2006.08.021
10.1021/ar7002804
10.1021/bc800108v
10.1002/anie.201008206
10.1155/2012/940585
10.1016/j.jcis.2009.10.073
10.1016/j.ejpb.2009.04.016
10.1371/journal.pone.0031875
10.2217/17435889.3.5.703
10.1517/17425247.2010.492212
10.1016/j.cis.2013.10.013
10.1021/bc050217o
10.1016/j.toxlet.2012.09.025
10.1158/1535-7163.MCT-10-0172
10.1007/s10549-010-1130-6
10.4103/0975-7406.76478
10.1007/s10544-007-9046-6
10.2967/jnumed.113.122630
10.1016/j.biomaterials.2010.07.069
10.1016/j.jconrel.2012.05.016
10.1038/nrd2591
10.1038/nature03794
10.1016/j.ijpharm.2006.03.052
10.1016/j.biomaterials.2009.03.010
10.1016/j.jconrel.2011.06.001
10.1016/j.jconrel.2009.10.014
10.1038/nbt1006-1211
10.1073/pnas.1103573108
10.1002/jps.22308
10.1007/978-1-60761-609-2_17
10.1002/jps.21944
10.1073/pnas.0600997103
10.1038/nrd1632
10.1038/srep02804
10.2217/nnm.11.19
10.1208/s12248-009-9116-1
10.1016/j.nano.2011.06.015
10.1016/j.fct.2012.07.005
10.1117/1.3120494
10.1007/s11095-007-9335-z
10.1186/1556-276X-6-321
10.1039/c0nr00345j
10.1002/cncr.26087
10.1088/0957-4484/21/28/285103
10.1016/j.ijpharm.2007.12.013
10.2147/IJN.S596
10.1021/mp900090z
10.1016/j.addr.2012.09.037
10.1186/2045-824X-3-3
10.1093/annonc/mdm374
10.1517/17425240902932908
10.2147/IJN.S16923
10.1155/2013/238428
10.1155/2011/469679
10.4137/DTI.S12519
10.1038/nrclinonc.2010.38
10.1021/bc700184b
10.18433/J3M59P
10.1016/j.addr.2009.05.005
10.1039/c2cs15327k
10.1021/jm060515m
10.1016/j.biomaterials.2011.06.066
10.1602/neurorx.2.1.108
10.1111/j.1469-0691.2012.03938.x
10.2217/17435889.1.3.297
10.1016/j.taap.2009.09.015
10.1021/ar2000138
10.3390/polym3031377
10.1146/annurev-bioeng-071811-150124
10.1016/j.taap.2009.05.026
10.1038/nrclinonc.2014.51
10.1136/bjo.49.4.205
10.1021/mp300350e
10.1016/j.tiv.2009.07.010
10.1096/fj.10-179192
10.1016/j.jaad.2011.10.031
10.1093/jmcb/mjp006
10.1016/j.jsps.2011.04.001
10.4155/tde.10.13
10.1016/j.bmc.2009.02.043
10.2147/IJN.S39426
10.1021/mp900015y
10.1016/j.jconrel.2010.01.036
10.1038/nrm2531
10.1038/sj.clpt.6100400
10.1021/la2011259
10.3109/07357900903179591
10.1016/j.ejso.2009.10.014
10.1016/j.nantod.2009.07.001
10.1016/j.apradiso.2011.05.002
10.1038/nbt1340
10.1016/j.ymeth.2011.02.005
10.3390/molecules17055564
10.1016/j.ijpharm.2007.01.031
10.1016/j.ijpharm.2005.10.010
10.1021/ja802318f
10.1093/toxsci/kfr192
10.1016/j.ejpb.2008.11.010
ContentType Journal Article
Copyright Springer Science+Business Media Dordrecht 2014
2015 INIST-CNRS
Copyright_xml – notice: Springer Science+Business Media Dordrecht 2014
– notice: 2015 INIST-CNRS
DBID AAYXX
CITATION
IQODW
3V.
7QO
7SR
7TB
7U5
7U7
7X7
7XB
8AO
8BQ
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABJCF
ABUWG
AEUYN
AFKRA
ARAPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
D1I
DWQXO
F28
FR3
FYUFA
GHDGH
GNUQQ
HCIFZ
JG9
K9.
KB.
L6V
L7M
LK8
M0S
M7P
M7S
P5Z
P62
P64
PDBOC
PHGZM
PHGZT
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PTHSS
DOI 10.1007/s11051-014-2527-7
DatabaseName CrossRef
Pascal-Francis
ProQuest Central (Corporate)
Biotechnology Research Abstracts
Engineered Materials Abstracts
Mechanical & Transportation Engineering Abstracts
Solid State and Superconductivity Abstracts
Toxicology Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
ProQuest Pharma Collection
METADEX
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Journals
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
Advanced Technologies & Aerospace Collection
ProQuest Central Essentials - QC
Biological Science Collection
ProQuest Central (New)
Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Materials Science Collection
ProQuest Central Korea
ANTE: Abstracts in New Technology & Engineering
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
Materials Research Database
ProQuest Health & Medical Complete (Alumni)
Materials Science Database
ProQuest Engineering Collection
Advanced Technologies Database with Aerospace
Biological Sciences
ProQuest Health & Medical Collection
Biological Science Database
Engineering Database
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
Materials Science Collection
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
Engineering Collection
DatabaseTitle CrossRef
Materials Research Database
ProQuest Central Student
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
SciTech Premium Collection
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Engineered Materials Abstracts
Health Research Premium Collection
Natural Science Collection
Biological Science Collection
ProQuest Central (New)
Engineering Collection
ANTE: Abstracts in New Technology & Engineering
Advanced Technologies & Aerospace Collection
Engineering Database
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Solid State and Superconductivity Abstracts
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
Mechanical & Transportation Engineering Abstracts
Materials Science Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Engineering Collection
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Materials Science Database
Advanced Technologies Database with Aerospace
ProQuest Materials Science Collection
Toxicology Abstracts
ProQuest SciTech Collection
METADEX
Advanced Technologies & Aerospace Database
Materials Science & Engineering Collection
ProQuest Central (Alumni)
DatabaseTitleList Materials Research Database
Materials Research Database

Database_xml – sequence: 1
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Engineering
Pharmacy, Therapeutics, & Pharmacology
Physics
EISSN 1572-896X
EndPage 25
ExternalDocumentID 3399194321
28734207
10_1007_s11051_014_2527_7
Genre Feature
GroupedDBID ---
-58
-5G
-BR
-EM
-Y2
-~C
.86
.VR
06C
06D
0R~
0VY
199
1N0
1SB
203
29L
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
3V.
4.4
406
408
409
40D
40E
53G
5GY
5VS
67Z
6NX
7X7
8AO
8FE
8FG
8FH
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDBF
ABDZT
ABECU
ABFTD
ABFTV
ABHLI
ABHQN
ABJCF
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABQBU
ABQSL
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACHSB
ACHXU
ACIWK
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACSNA
ACUHS
ACZOJ
ADBBV
ADHHG
ADHIR
ADINQ
ADKNI
ADKPE
ADMLS
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEUYN
AEVLU
AEXYK
AFBBN
AFGCZ
AFKRA
AFLOW
AFQWF
AFRAH
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARAPS
ARMRJ
ASPBG
AVWKF
AXYYD
AYJHY
AZFZN
B-.
BA0
BBNVY
BDATZ
BENPR
BGLVJ
BGNMA
BHPHI
BPHCQ
BSONS
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
D1I
DDRTE
DL5
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
EIOEI
EJD
ESBYG
ESX
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GXS
H13
HCIFZ
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I-F
I09
IHE
IJ-
IKXTQ
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KB.
KDC
KOV
L6V
LAK
LK8
LLZTM
M4Y
M7P
M7S
MA-
MM.
N2Q
NB0
NPVJJ
NQJWS
NU0
O9-
O93
O9J
OAM
OVD
P2P
P62
P9N
PDBOC
PF0
PQQKQ
PROAC
PT4
PT5
PTHSS
QOR
QOS
R89
R9I
RNI
RNS
ROL
RPX
RSV
RZC
RZE
RZK
S16
S1Z
S27
S3B
SAP
SCM
SDH
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
STPWE
SZN
T13
TEORI
TSG
TSK
TSV
TUC
TUS
U2A
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
YLTOR
Z45
Z5O
Z7R
Z7S
Z7U
Z7V
Z7W
Z7X
Z7Y
Z7Z
Z81
Z83
Z85
Z88
ZMTXR
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
IQODW
7QO
7SR
7TB
7U5
7U7
7XB
8BQ
8FD
8FK
ABRTQ
AZQEC
C1K
DWQXO
F28
FR3
GNUQQ
JG9
K9.
L7M
P64
PKEHL
PQEST
PQGLB
PQUKI
ID FETCH-LOGICAL-c445t-6987d15f9be54b45b7b4ddf90cfb58e15ff5f75c71ba73cabd6385af2b2226583
IEDL.DBID 7X7
ISSN 1388-0764
IngestDate Mon Jul 21 10:12:47 EDT 2025
Fri Jul 25 11:07:41 EDT 2025
Wed Apr 02 07:25:11 EDT 2025
Thu Apr 24 23:06:26 EDT 2025
Tue Jul 01 04:31:31 EDT 2025
Fri Feb 21 02:32:44 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords Health effects
Drug delivery
Route of administration
Nano-drug
Imaging
Drug
Drug delivery systems
Biodegradability
Nanoparticle
Drug carrier
Review
Physical properties
Detector
Nanostructured materials
Medical application
Physicochemical properties
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c445t-6987d15f9be54b45b7b4ddf90cfb58e15ff5f75c71ba73cabd6385af2b2226583
Notes SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-2
content type line 23
PQID 1552567608
PQPubID 1456352
PageCount 25
ParticipantIDs proquest_miscellaneous_1567081172
proquest_journals_1552567608
pascalfrancis_primary_28734207
crossref_primary_10_1007_s11051_014_2527_7
crossref_citationtrail_10_1007_s11051_014_2527_7
springer_journals_10_1007_s11051_014_2527_7
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20140800
PublicationDateYYYYMMDD 2014-08-01
PublicationDate_xml – month: 8
  year: 2014
  text: 20140800
PublicationDecade 2010
PublicationPlace Dordrecht
PublicationPlace_xml – name: Dordrecht
PublicationSubtitle An Interdisciplinary Forum for Nanoscale Science and Technology
PublicationTitle Journal of nanoparticle research : an interdisciplinary forum for nanoscale science and technology
PublicationTitleAbbrev J Nanopart Res
PublicationYear 2014
Publisher Springer Netherlands
Springer
Springer Nature B.V
Publisher_xml – name: Springer Netherlands
– name: Springer
– name: Springer Nature B.V
References Mieog, Hutteman, van der Vorst, Kuppen, Que, Dijkstra, Kaijzel, Prins, Lowik, Smit, van de Velde, Vahrmeijer (CR73) 2011; 128
Amin (CR6) 2013; 7
Hu, Gao (CR46) 2010; 394
Te Velde, Veerman, Subramaniam, Ruers (CR119) 2010; 36
Owens, Peppas (CR82) 2006; 307
Polom, Murawa, Rho, Nowaczyk, Hunerbein, Murawa (CR94) 2011; 117
Mandal, Bakeine, Krol, Ferrari, Clerici, Zonta, Cansolino, Ballarini, Bortolussi, Stella, Protti, Bruschi, Altieri (CR69) 2011; 69
Alander, Kaartinen, Laakso, Patila, Spillmann, Tuchin, Venermo, Valisuo (CR2) 2012; 2012
Harasym, Tardi, Harasym, Harvie, Johnstone, Mayer (CR40) 2007; 16
Chipman, Oldham, Pezzoni, Singer (CR21) 2006; 1
Zhang, Liu, Su, Luo, Zhu, Tan, Fan, Zhang, Zhou, Cheng, Shi (CR138) 2010; 31
Zhang, Choi, Eum, Daunert, Toborek (CR139) 2013; 8
Di Pasqua, Wallner, Kerwood, Dabrowiak (CR28) 2009; 6
Eom, Choi (CR31) 2009; 23
CR155
CR156
CR153
Kularatne, Low (CR58) 2010; 624
CR154
Tosi, Bortot, Ruozi, Dolcetta, Vandelli, Forni, Severini (CR123) 2013; 20
Qi, Gao, Tang, He, Liu, He, Sun, Li, Li, Liu (CR98) 2009; 11
Gullotti, Yeo (CR38) 2009; 6
Liu, Zhang, Slutsky (CR63) 2009; 1
Paolino, Muzzalupo, Ricciardi, Celia, Picci, Fresta (CR86) 2007; 9
Shaikh, Raj Singh, Garland, Woolfson, Donnelly (CR109) 2011; 3
Zhu, Feng, Wang, Wang, Wang, Ouyang, Zhao, Chai (CR140) 2009; 107
Aktas, Yemisci, Andrieux, Gursoy, Alonso, Fernandez-Megia, Novoa-Carballal, Quinoa, Riguera, Sargon, Celik, Demir, Hincal, Dalkara, Capan, Couvreur (CR1) 2005; 16
Baker, Gupta, Clark, Valenzuela, Staska, Harbo, Pierce, Dill (CR10) 2008; 101
Champion, Mitragotri (CR19) 2006; 103
Merian, Gravier, Navarro, Texier (CR72) 2012; 17
He, Zhang, Ma, Bai, Zhang, Lu, Ding, Zhao, Chai (CR41) 2010; 21
Uner, Yener (CR127) 2007; 2
Popovici, Seftel, Mihai, Popovici, Voicu (CR95) 2011; 100
Taheri, Dinarvand, Atyabi, Ahadi, Nouri, Ghahremani, Ostad, Borougeni, Mansoori (CR116) 2011; 12
Pittet, Posfay-Barbe (CR93) 2012; 18
Wang (CR129) 2011; 1
Fernandez-Suarez, Ting (CR34) 2008; 9
De Jong, Borm (CR26) 2008; 3
Rao, Dragulescu-Andrasi, Yao (CR99) 2007; 18
Simonetti, Gelfuso, Barbosa, Lopez (CR111) 2009; 73
Decuzzi, Godin, Tanaka, Lee, Chiappini, Liu, Ferrari (CR27) 2010; 141
Koc, Anik, Cabuk, Ceylan (CR56) 2008; 22
Foulds, Mitchell, Parker, Turner, Green, Diggle, Hasegawa, Taylor, Mann, Allsop (CR35) 2011; 25
Wilson, Danenberg, Johnston, Lenz, Ladner (CR134) 2014; 11
Alexis, Pridgen, Molnar, Farokhzad (CR4) 2008; 5
Paolino, Cosco, Muzzalupo, Trapasso, Picci, Fresta (CR87) 2008; 353
Wang, Huang, Yeh (CR130) 2011; 27
Choi, Zuckerman, Webster, Davis (CR24) 2011; 108
Kadam, Bourne, Kompella (CR54) 2012; 40
Tan, Luo, Wang, Su, Cheng, Shi (CR117) 2012; 33
Bertrand, Wu, Xu, Kamaly, Farokhzad (CR15) 2014; 66
Hong, Lee, Zheng, Hong, Lee (CR45) 2011; 6
Pandey, Khuller (CR85) 2005; 85
Savic, Azzam, Eisenberg, Maysinger (CR105) 2006; 22
Puvanakrishnan, Park, Diagaradjane, Schwartz, Coleman, Gill-Sharp, Sang, Payne, Krishnan, Tunnell (CR97) 2009; 14
Tseng, Su, Yen, Yang, Lin (CR126) 2009; 30
CR151
CR152
Jokerst, Lobovkina, Zare, Gambhir (CR53) 2011; 6
CR150
Shinohara, Gamo, Nakanishi (CR110) 2011; 123
Spuch, Navarro (CR114) 2011; 2011
Sahay, Alakhova, Kabanov (CR102) 2010; 145
Sato, Anzai (CR104) 2013; 18
CR148
CR149
CR146
Longmire, Choyke, Kobayashi (CR64) 2008; 3
Pavlov, Perevyazko, Okatova, Schubert (CR90) 2011; 54
Jain, Huang, El-Sayed, El-Sayed (CR50) 2008; 41
CR147
Wagner, Dullaart, Bock, Zweck (CR128) 2006; 24
CR144
CR145
CR142
CR143
Murata, Yonamine, Tanaka, Tahara, Tozuka, Takeuchi (CR77) 2013; 102
Muro, Garnacho, Champion, Leferovich, Gajewski, Schuchman, Mitragotri, Muzykantov (CR78) 2008; 16
Sousa, Mandal, Garrovo, Astolfo, Bonifacio, Latawiec, Menk, Arfelli, Huewel, Legname, Galla, Krol (CR113) 2010; 2
Azarmi, Tao, Chen, Wang, Finlay, Lobenberg, Roa (CR7) 2006; 319
Bayindir, Yuksel (CR14) 2010; 99
Herai, Gratieri, Thomazine, Bentley, Lopez (CR43) 2007; 329
Taylor, Moore, Mourtas, Niarakis, Re, Zona, La Ferla, Nicotra, Masserini, Antimisiaris, Gregori, Allsop (CR118) 2011; 7
Maeda, Bharate, Daruwalla (CR66) 2009; 71
Napierska, Thomassen, Lison, Martens, Hoet (CR80) 2010; 7
Barreto, O’Malley, Kubeil, Graham, Stephan, Spiccia (CR12) 2011; 23
Paino, Marangoni, de Oliveira, Antunes, Zucolotto (CR83) 2012; 215
Guterres, Alves, Pohlmann (CR39) 2007; 2
Makadia, Siegel (CR68) 2011; 3
Hong, Zhang, Sun, Cai (CR44) 2009; 4
Pan, Wang, Al-Suwayeh, Huang, Fang (CR84) 2012; 50
Immordino, Dosio, Cattel (CR49) 2006; 1
Badr, Tannous (CR8) 2011; 29
Cai, Vijayan, Cheng, Lima, Discher (CR17) 2007; 24
Sakhtianchi, Minchin, Lee, Alkilany, Serpooshan, Mahmoudi (CR103) 2013; 201–202
Olivier (CR81) 2005; 2
Wilczewska, Niemirowicz, Markiewicz, Car (CR133) 2012; 64
Camp, Wang, Little, Watson, Pirollo, Rait, Cole, Chang, Watson (CR18) 2013; 20
Liu, Sun (CR62) 2010; 31
Trabelsi, Azzouz, Sakly, Abdelmelek (CR124) 2013; 8
Majoros, Williams, Becker, Baker (CR67) 2009; 6
Choi, Liu, Misra, Tanaka, Zimmer, Itty Ipe, Bawendi, Frangioni (CR23) 2007; 25
Jarrett, Gustafsson, Kukis, Louie (CR51) 2008; 19
Hu, Aryal, Zhang (CR47) 2010; 1
Bae, Park (CR9) 2011; 153
Trewyn, Giri, Slowing, Lin (CR125) 2007; 31
Huang, Zhang, Bi, Dou (CR48) 2008; 355
Cho, Cho, Kim, Choi, Lee, Han, Park, Yu, Jon, Jeong (CR22) 2009; 239
Gindy, Prud’homme (CR37) 2009; 6
Sadauskas, Wallin, Stoltenberg, Vogel, Doering, Larsen, Danscher (CR100) 2007; 4
Ding, Ma (CR29) 2013; 3
Xie, Mol, Keereweer, van Beek, Que, Snoeks, Chan, Kaijzel, Lowik (CR136) 2012; 7
Sengupta, Eavarone, Capila, Zhao, Watson, Kiziltepe, Sasisekharan (CR107) 2005; 436
Torchilin (CR121) 2005; 4
Chen, Kim, He, Wang, Low, Park, Cheng (CR20) 2008; 24
Wang, Byrne, Napier, DeSimone (CR131) 2011; 7
Wang, He, Zhang, Zhao, Feng (CR132) 2013; 46
Slowing, Vivero-Escoto, Wu, Lin (CR112) 2008; 60
Mortimer, Bading, Colcher, Conti, Frankel, Carroll, Tong, Poku, Miles, Shively, Raubitschek (CR75) 2014; 55
Czarnobaj (CR25) 2008; 15
Park (CR88) 2012; 160
Scheinberg, Villa, Escorcia, McDevitt (CR106) 2010; 7
Masserini (CR70) 2013; 2013
Albanese, Tang, Chan (CR3) 2012; 14
Gao, Tao, Lu, Zhang, Zhang, Jiang, Fu (CR36) 2006; 27
Lai, Wang, Hanes (CR59) 2009; 61
Prausnitz, Langer (CR96) 2008; 26
Johnston, Semmler-Behnke, Brown, Kreyling, Tran, Stone (CR52) 2010; 242
Banerjee, Harfouche, Sengupta (CR11) 2011; 3
Pereverzeva, Treschalin, Bodyagin, Maksimenko, Langer, Dreis, Asmussen, Kreuter, Gelperina (CR91) 2007; 337
Torchilin (CR122) 2007; 9
He, Gao, Zhang, Zhang, Gao, Ji, Li, Shi (CR42) 2011; 32
Allen, Cullis (CR5) 2013; 65
Zhuang, Kuo, Chou, Liu, Weerapana, Tsung (CR141) 2014; 8
Sadauskas, Danscher, Stoltenberg, Vogel, Larsen, Wallin (CR101) 2009; 5
Thakor, Gambhir (CR120) 2013
Nair, Jagadeeshan, Nair, Kumar (CR79) 2011; 6
Park, Lee, Kim, Park, Kim, Kwon (CR89) 2008; 33
Kamaly, Xiao, Valencia, Radovic-Moreno, Farokhzad (CR55) 2012; 41
Fenton (CR33) 1965; 49
Batrakova, Li, Reynolds, Mosley, Bronich, Kabanov, Gendelman (CR13) 2007; 18
Svenson, Tomalia (CR115) 2005; 57
Bisht, Mizuma, Feldmann, Ottenhof, Hong, Pramanik, Chenna, Karikari, Sharma, Goggins, Rudek, Ravi, Maitra, Maitra (CR16) 2010; 9
Faraji, Wipf (CR32) 2009; 17
Elsabahy, Wooley (CR30) 2012; 41
Li, Su, Cheng, Deng (CR60) 2010; 342
Montet, Funovics, Montet-Abou, Weissleder, Josephson (CR74) 2006; 49
Petros, DeSimone (CR92) 2010; 9
Lv, Yu, Xi, Li, Song, Cui, Cao, Zhai (CR65) 2009; 372
Sevick-Muraca (CR108) 2012; 63
Krishnan, Xu, Barwe, Yang, Czymmek, Waldman, Mason, Jia, Rajasekaran (CR57) 2013; 10
Medina, Santos-Martinez, Radomski, Corrigan, Radomski (CR71) 2007; 150
Li, Zhou, Wang, Perrett, Zhao, Tang, Nie (CR61) 2011; 50
Mudshinge, Deore, Patil, Bhalgat (CR76) 2011; 19
Wortmann, Vohringer, Engler, Corjon, Schirmbeck, Reimann, Kochanek, Kreppel (CR135) 2008; 16
Zhang, Gu, Chan, Wang, Langer, Farokhzad (CR137) 2008; 83
Y Li (2527_CR61) 2011; 50
E Sadauskas (2527_CR101) 2009; 5
H Herai (2527_CR43) 2007; 329
Q Lv (2527_CR65) 2009; 372
P Decuzzi (2527_CR27) 2010; 141
C Medina (2527_CR71) 2007; 150
N Bertrand (2527_CR15) 2014; 66
H Maeda (2527_CR66) 2009; 71
J Rao (2527_CR99) 2007; 18
PG Foulds (2527_CR35) 2011; 25
SR Mudshinge (2527_CR76) 2011; 19
N Kamaly (2527_CR55) 2012; 41
EM Sevick-Muraca (2527_CR108) 2012; 63
EV Batrakova (2527_CR13) 2007; 18
C Hong (2527_CR45) 2011; 6
J Merian (2527_CR72) 2012; 17
R Pandey (2527_CR85) 2005; 85
YH Bae (2527_CR9) 2011; 153
JT Alander (2527_CR2) 2012; 2012
KL Nair (2527_CR79) 2011; 6
V Wagner (2527_CR128) 2006; 24
ER Camp (2527_CR18) 2013; 20
IJ Majoros (2527_CR67) 2009; 6
AS Thakor (2527_CR120) 2013
BG Trewyn (2527_CR125) 2007; 31
D Banerjee (2527_CR11) 2011; 3
R Savic (2527_CR105) 2006; 22
ML Amin (2527_CR6) 2013; 7
G Sahay (2527_CR102) 2010; 145
K Park (2527_CR88) 2012; 160
R Qi (2527_CR98) 2009; 11
R Sakhtianchi (2527_CR103) 2013; 201–202
BW Xie (2527_CR136) 2012; 7
JH Park (2527_CR89) 2008; 33
A Wortmann (2527_CR135) 2008; 16
M Murata (2527_CR77) 2013; 102
S Muro (2527_CR78) 2008; 16
G Huang (2527_CR48) 2008; 355
H Hong (2527_CR44) 2009; 4
F Alexis (2527_CR4) 2008; 5
S Svenson (2527_CR115) 2005; 57
HS Choi (2527_CR23) 2007; 25
CL Tseng (2527_CR126) 2009; 30
K Koc (2527_CR56) 2008; 22
SS Guterres (2527_CR39) 2007; 2
HJ Eom (2527_CR31) 2009; 23
A Taheri (2527_CR116) 2011; 12
A Albanese (2527_CR3) 2012; 14
S Azarmi (2527_CR7) 2006; 319
F Sousa (2527_CR113) 2010; 2
HM Ding (2527_CR29) 2013; 3
PJ Fenton (2527_CR33) 1965; 49
LF Pittet (2527_CR93) 2012; 18
R Shaikh (2527_CR109) 2011; 3
H Chen (2527_CR20) 2008; 24
X Liu (2527_CR62) 2010; 31
DA Scheinberg (2527_CR106) 2010; 7
Q He (2527_CR42) 2011; 32
2527_CR151
2527_CR150
Y Aktas (2527_CR1) 2005; 16
ZS Bayindir (2527_CR14) 2010; 99
LD Simonetti (2527_CR111) 2009; 73
M Uner (2527_CR127) 2007; 2
JS Mieog (2527_CR73) 2011; 128
BR Jarrett (2527_CR51) 2008; 19
TL Pan (2527_CR84) 2012; 50
X He (2527_CR41) 2010; 21
2527_CR156
2527_CR155
2527_CR154
2527_CR153
2527_CR152
AH Faraji (2527_CR32) 2009; 17
E Pereverzeva (2527_CR91) 2007; 337
M Taylor (2527_CR118) 2011; 7
P Puvanakrishnan (2527_CR97) 2009; 14
YL Hu (2527_CR46) 2010; 394
VP Torchilin (2527_CR121) 2005; 4
2527_CR148
G Tosi (2527_CR123) 2013; 20
2527_CR147
2527_CR146
M Liu (2527_CR63) 2009; 1
2527_CR145
EA Velde Te (2527_CR119) 2010; 36
2527_CR144
YX Wang (2527_CR129) 2011; 1
2527_CR143
D Paolino (2527_CR87) 2008; 353
2527_CR142
HK Makadia (2527_CR68) 2011; 3
K Czarnobaj (2527_CR25) 2008; 15
S Sengupta (2527_CR107) 2005; 436
N Shinohara (2527_CR110) 2011; 123
SK Lai (2527_CR59) 2009; 61
IM Paino (2527_CR83) 2012; 215
2527_CR149
JA Barreto (2527_CR12) 2011; 23
E Sadauskas (2527_CR100) 2007; 4
H Trabelsi (2527_CR124) 2013; 8
B Zhang (2527_CR139) 2013; 8
C Spuch (2527_CR114) 2011; 2011
X Montet (2527_CR74) 2006; 49
DE Owens 3rd (2527_CR82) 2006; 307
VP Torchilin (2527_CR122) 2007; 9
L Zhang (2527_CR137) 2008; 83
X Tan (2527_CR117) 2012; 33
S Bisht (2527_CR16) 2010; 9
M Longmire (2527_CR64) 2008; 3
PM Wilson (2527_CR134) 2014; 11
ME Gindy (2527_CR37) 2009; 6
GL Baker (2527_CR10) 2008; 101
C Zhang (2527_CR138) 2010; 31
D Paolino (2527_CR86) 2007; 9
JC Olivier (2527_CR81) 2005; 2
K Sato (2527_CR104) 2013; 18
M Fernandez-Suarez (2527_CR34) 2008; 9
AZ Wilczewska (2527_CR133) 2012; 64
TO Harasym (2527_CR40) 2007; 16
E Gullotti (2527_CR38) 2009; 6
TM Allen (2527_CR5) 2013; 65
CH Choi (2527_CR24) 2011; 108
J Wang (2527_CR131) 2011; 7
WH Jong De (2527_CR26) 2008; 3
CE Badr (2527_CR8) 2011; 29
M Masserini (2527_CR70) 2013; 2013
J Zhuang (2527_CR141) 2014; 8
S Mandal (2527_CR69) 2011; 69
B Wang (2527_CR132) 2013; 46
WS Cho (2527_CR22) 2009; 239
X Gao (2527_CR36) 2006; 27
MR Prausnitz (2527_CR96) 2008; 26
ML Immordino (2527_CR49) 2006; 1
D Napierska (2527_CR80) 2010; 7
JE Mortimer (2527_CR75) 2014; 55
II Slowing (2527_CR112) 2008; 60
RA Petros (2527_CR92) 2010; 9
S Cai (2527_CR17) 2007; 24
CM Hu (2527_CR47) 2010; 1
CH Wang (2527_CR130) 2011; 27
K Polom (2527_CR94) 2011; 117
RS Kadam (2527_CR54) 2012; 40
M Elsabahy (2527_CR30) 2012; 41
MT Zhu (2527_CR140) 2009; 107
JA Champion (2527_CR19) 2006; 103
RF Popovici (2527_CR95) 2011; 100
GM Pavlov (2527_CR90) 2011; 54
JV Jokerst (2527_CR53) 2011; 6
Z Li (2527_CR60) 2010; 342
SA Kularatne (2527_CR58) 2010; 624
V Krishnan (2527_CR57) 2013; 10
SD Chipman (2527_CR21) 2006; 1
HJ Johnston (2527_CR52) 2010; 242
AJ Pasqua Di (2527_CR28) 2009; 6
PK Jain (2527_CR50) 2008; 41
References_xml – ident: CR150
– volume: 16
  start-page: 1503
  issue: 6
  year: 2005
  end-page: 1511
  ident: CR1
  article-title: Development and brain delivery of chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26
  publication-title: Bioconjug Chem
– volume: 64
  start-page: 1020
  issue: 5
  year: 2012
  end-page: 1037
  ident: CR133
  article-title: Nanoparticles as drug delivery systems
  publication-title: Pharmacol Rep
– volume: 69
  start-page: 1692
  issue: 12
  year: 2011
  end-page: 1697
  ident: CR69
  article-title: Design, development and characterization of multi-functionalized gold nanoparticles for biodetection and targeted boron delivery in BNCT applications
  publication-title: Appl Radiat Isot
– volume: 60
  start-page: 1278
  issue: 11
  year: 2008
  end-page: 1288
  ident: CR112
  article-title: Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers
  publication-title: Adv Drug Deliv Rev
– volume: 50
  start-page: 3892
  issue: 11
  year: 2012
  end-page: 3901
  ident: CR84
  article-title: Toxicological effects of cationic nanobubbles on the liver and kidneys: biomarkers for predicting the risk
  publication-title: Food Chem Toxicol
– volume: 25
  start-page: 1165
  issue: 10
  year: 2007
  end-page: 1170
  ident: CR23
  article-title: Renal clearance of quantum dots
  publication-title: Nat Biotechnol
– volume: 32
  start-page: 7711
  issue: 30
  year: 2011
  end-page: 7720
  ident: CR42
  article-title: A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance
  publication-title: Biomaterials
– volume: 307
  start-page: 93
  issue: 1
  year: 2006
  end-page: 102
  ident: CR82
  article-title: Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
  publication-title: Int J Pharm
– volume: 22
  start-page: 99
  issue: 1
  year: 2008
  end-page: 103
  ident: CR56
  article-title: Fluorescein sodium-guided surgery in glioblastoma multiforme: a prospective evaluation
  publication-title: Br J Neurosurg
– volume: 50
  start-page: 5860
  issue: 26
  year: 2011
  end-page: 5864
  ident: CR61
  article-title: Chirality of glutathione surface coating affects the cytotoxicity of quantum dots
  publication-title: Angew Chem
– volume: 160
  start-page: 1
  issue: 1
  year: 2012
  end-page: 2
  ident: CR88
  article-title: Toxicity risk of nanocarriers
  publication-title: J Control Release
– volume: 29
  start-page: 624
  issue: 12
  year: 2011
  end-page: 633
  ident: CR8
  article-title: Bioluminescence imaging: progress and applications
  publication-title: Trends Biotechnol
– volume: 31
  start-page: 3236
  year: 2007
  end-page: 3245
  ident: CR125
  article-title: Mesoporous silica nanoparticle based controlled release, drug delivery, and biosensor systems
  publication-title: Chem Commun (Camb)
– volume: 6
  start-page: 715
  issue: 4
  year: 2011
  end-page: 728
  ident: CR53
  article-title: Nanoparticle PEGylation for imaging and therapy
  publication-title: Nanomedicine (Lond)
– volume: 11
  start-page: 282
  issue: 5
  year: 2014
  end-page: 298
  ident: CR134
  article-title: Standing the test of time: targeting thymidylate biosynthesis in cancer therapy
  publication-title: Nat Rev Clin Oncol
– volume: 24
  start-page: 5213
  issue: 10
  year: 2008
  end-page: 5217
  ident: CR20
  article-title: Fast release of lipophilic agents from circulating PEG–PDLLA micelles revealed by in vivo forster resonance energy transfer imaging
  publication-title: Langmuir
– volume: 57
  start-page: 2106
  issue: 15
  year: 2005
  end-page: 2129
  ident: CR115
  article-title: Dendrimers in biomedical applications–reflections on the field
  publication-title: Adv Drug Deliv Rev
– volume: 46
  start-page: 761
  issue: 3
  year: 2013
  end-page: 769
  ident: CR132
  article-title: Metabolism of nanomaterials in vivo: blood circulation and organ clearance
  publication-title: Acc Chem Res
– volume: 7
  start-page: 27
  year: 2013
  end-page: 34
  ident: CR6
  article-title: P-glycoprotein inhibition for optimal drug delivery
  publication-title: Drug target insights
– ident: CR144
– volume: 1
  start-page: 6
  issue: 1
  year: 2009
  end-page: 7
  ident: CR63
  article-title: Acute lung injury: a yellow card for engineered nanoparticles?
  publication-title: J Mol Cell Biol
– volume: 22
  start-page: 3570
  issue: 8
  year: 2006
  end-page: 3578
  ident: CR105
  article-title: Assessment of the integrity of poly(caprolactone)-b-poly(ethylene oxide) micelles under biological conditions: a fluorogenic-based approach
  publication-title: Langmuir
– volume: 3
  start-page: 89
  issue: 1
  year: 2011
  end-page: 100
  ident: CR109
  article-title: Mucoadhesive drug delivery systems
  publication-title: J Pharm Bioallied Sci
– volume: 372
  start-page: 191
  issue: 1–2
  year: 2009
  end-page: 198
  ident: CR65
  article-title: Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery
  publication-title: Int J Pharm
– ident: CR153
– volume: 11
  start-page: 395
  issue: 3
  year: 2009
  end-page: 405
  ident: CR98
  article-title: PEG-conjugated PAMAM dendrimers mediate efficient intramuscular gene expression
  publication-title: AAPS J
– volume: 9
  start-page: 615
  issue: 8
  year: 2010
  end-page: 627
  ident: CR92
  article-title: Strategies in the design of nanoparticles for therapeutic applications
  publication-title: Nat Rev Drug Discov
– volume: 65
  start-page: 36
  issue: 1
  year: 2013
  end-page: 48
  ident: CR5
  article-title: Liposomal drug delivery systems: from concept to clinical applications
  publication-title: Adv Drug Deliv Rev
– volume: 107
  start-page: 342
  issue: 2
  year: 2009
  end-page: 351
  ident: CR140
  article-title: Particokinetics and extrapulmonary translocation of intratracheally instilled ferric oxide nanoparticles in rats and the potential health risk assessment
  publication-title: Toxicol Sci
– volume: 6
  start-page: 1430
  issue: 7
  year: 2009
  end-page: 1436
  ident: CR67
  article-title: Surface interaction and behavior of poly(amidoamine) dendrimers: deformability and lipid bilayer disruption
  publication-title: J Comput Theor Nanosci
– volume: 103
  start-page: 4930
  issue: 13
  year: 2006
  end-page: 4934
  ident: CR19
  article-title: Role of target geometry in phagocytosis
  publication-title: Proc Natl Acad Sci USA
– volume: 23
  start-page: 1326
  issue: 7
  year: 2009
  end-page: 1332
  ident: CR31
  article-title: Oxidative stress of silica nanoparticles in human bronchial epithelial cell, Beas-2B
  publication-title: Toxicol In Vitro
– volume: 6
  start-page: 1685
  year: 2011
  end-page: 1697
  ident: CR79
  article-title: Biological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier, PLGA
  publication-title: Int J Nanomed
– volume: 117
  start-page: 4812
  issue: 21
  year: 2011
  end-page: 4822
  ident: CR94
  article-title: Current trends and emerging future of indocyanine green usage in surgery and oncology: a literature review
  publication-title: Cancer
– volume: 215
  start-page: 119
  issue: 2
  year: 2012
  end-page: 125
  ident: CR83
  article-title: Cyto and genotoxicity of gold nanoparticles in human hepatocellular carcinoma and peripheral blood mononuclear cells
  publication-title: Toxicol Lett
– volume: 31
  start-page: 6612
  issue: 25
  year: 2010
  end-page: 6617
  ident: CR138
  article-title: A near-infrared fluorescent heptamethine indocyanine dye with preferential tumor accumulation for in vivo imaging
  publication-title: Biomaterials
– volume: 18
  start-page: 8440
  issue: 7
  year: 2013
  end-page: 8460
  ident: CR104
  article-title: Dendrimers in layer-by-layer assemblies: synthesis and applications
  publication-title: Molecules
– ident: CR147
– volume: 85
  start-page: 227
  issue: 4
  year: 2005
  end-page: 234
  ident: CR85
  article-title: Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis
  publication-title: Tuberculosis (Edinb)
– volume: 6
  start-page: 321
  issue: 1
  year: 2011
  ident: CR45
  article-title: Porous silicon nanoparticles for cancer photothermotherapy
  publication-title: Nanoscale Res Lett
– volume: 19
  start-page: 1496
  issue: 7
  year: 2008
  end-page: 1504
  ident: CR51
  article-title: Synthesis of 64Cu-labeled magnetic nanoparticles for multimodal imaging
  publication-title: Bioconjug Chem
– ident: CR156
– volume: 26
  start-page: 1261
  issue: 11
  year: 2008
  end-page: 1268
  ident: CR96
  article-title: Transdermal drug delivery
  publication-title: Nat Biotechnol
– volume: 3
  start-page: 3
  issue: 1
  year: 2011
  ident: CR11
  article-title: Nanotechnology-mediated targeting of tumor angiogenesis
  publication-title: Vasc Cell
– volume: 24
  start-page: 2099
  issue: 11
  year: 2007
  end-page: 2109
  ident: CR17
  article-title: Micelles of different morphologies—advantages of worm-like filomicelles of PEO–PCL in paclitaxel delivery
  publication-title: Pharm Res
– volume: 7
  start-page: 541
  issue: 5
  year: 2011
  end-page: 550
  ident: CR118
  article-title: Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer’s abeta peptide
  publication-title: Nanomed Nanotechnol Biol Med
– volume: 63
  start-page: 217
  year: 2012
  end-page: 231
  ident: CR108
  article-title: Translation of near-infrared fluorescence imaging technologies: emerging clinical applications
  publication-title: Annu Rev Med
– volume: 337
  start-page: 346
  issue: 1–2
  year: 2007
  end-page: 356
  ident: CR91
  article-title: Influence of the formulation on the tolerance profile of nanoparticle-bound doxorubicin in healthy rats: focus on cardio- and testicular toxicity
  publication-title: Int J Pharm
– volume: 353
  start-page: 233
  issue: 1–2
  year: 2008
  end-page: 242
  ident: CR87
  article-title: Innovative bola-surfactant niosomes as topical delivery systems of 5-fluorouracil for the treatment of skin cancer
  publication-title: Int J Pharm
– volume: 9
  start-page: 2255
  issue: 8
  year: 2010
  end-page: 2264
  ident: CR16
  article-title: Systemic administration of polymeric nanoparticle-encapsulated curcumin (NanoCurc) blocks tumor growth and metastases in preclinical models of pancreatic cancer
  publication-title: Mol Cancer Ther
– volume: 41
  start-page: 2971
  issue: 7
  year: 2012
  end-page: 3010
  ident: CR55
  article-title: Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
  publication-title: Chem Soc Rev
– volume: 18
  start-page: 25
  issue: Suppl 5
  year: 2012
  end-page: 36
  ident: CR93
  article-title: Pneumococcal vaccines for children: a global public health priority
  publication-title: Clin Microbiol Infect
– volume: 355
  start-page: 314
  issue: 1–2
  year: 2008
  end-page: 320
  ident: CR48
  article-title: Solid lipid nanoparticles of temozolomide: potential reduction of cardial and nephric toxicity
  publication-title: Int J Pharm
– volume: 17
  start-page: 5564
  issue: 5
  year: 2012
  end-page: 5591
  ident: CR72
  article-title: Fluorescent nanoprobes dedicated to in vivo imaging: from preclinical validations to clinical translation
  publication-title: Molecules
– volume: 5
  start-page: 505
  issue: 4
  year: 2008
  end-page: 515
  ident: CR4
  article-title: Factors affecting the clearance and biodistribution of polymeric nanoparticles
  publication-title: Mol Pharm
– ident: CR142
– volume: 9
  start-page: E128
  issue: 2
  year: 2007
  end-page: E147
  ident: CR122
  article-title: Targeted pharmaceutical nanocarriers for cancer therapy and imaging
  publication-title: AAPS J
– volume: 99
  start-page: 2049
  issue: 4
  year: 2010
  end-page: 2060
  ident: CR14
  article-title: Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery
  publication-title: J Pharm Sci
– volume: 3
  start-page: 2804
  year: 2013
  ident: CR29
  article-title: Controlling cellular uptake of nanoparticles with pH-sensitive polymers
  publication-title: Sci Rep
– volume: 8
  start-page: e63159
  issue: 5
  year: 2013
  ident: CR139
  article-title: TLR4 signaling is involved in brain vascular toxicity of PCB153 bound to nanoparticles
  publication-title: PLoS One
– volume: 2
  start-page: 2826
  issue: 12
  year: 2010
  end-page: 2834
  ident: CR113
  article-title: Functionalized gold nanoparticles: a detailed in vivo multimodal microscopic brain distribution study
  publication-title: Nanoscale
– volume: 394
  start-page: 115
  issue: 1–2
  year: 2010
  end-page: 121
  ident: CR46
  article-title: Potential neurotoxicity of nanoparticles
  publication-title: Int J Pharm
– ident: CR151
– volume: 7
  start-page: 1919
  issue: 14
  year: 2011
  end-page: 1931
  ident: CR131
  article-title: More effective nanomedicines through particle design
  publication-title: Small
– volume: 49
  start-page: 205
  year: 1965
  end-page: 208
  ident: CR33
  article-title: Applanation tonometry using one drop of an anaesthetic-fluorescein mixture
  publication-title: Br J Ophthalmol
– volume: 141
  start-page: 320
  issue: 3
  year: 2010
  end-page: 327
  ident: CR27
  article-title: Size and shape effects in the biodistribution of intravascularly injected particles
  publication-title: J Control Release
– volume: 4
  start-page: 10
  year: 2007
  ident: CR100
  article-title: Kupffer cells are central in the removal of nanoparticles from the organism
  publication-title: Part Fibre Toxicol
– volume: 6
  start-page: 1041
  issue: 4
  year: 2009
  end-page: 1051
  ident: CR38
  article-title: Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery
  publication-title: Mol Pharm
– volume: 2012
  start-page: 940585
  year: 2012
  ident: CR2
  article-title: A review of indocyanine green fluorescent imaging in surgery
  publication-title: Int J Biomed Imaging
– volume: 20
  start-page: 222
  issue: 4
  year: 2013
  end-page: 228
  ident: CR18
  article-title: Transferrin receptor targeting nanomedicine delivering wild-type p53 gene sensitizes pancreatic cancer to gemcitabine therapy
  publication-title: Cancer Gene Ther
– ident: CR145
– volume: 2013
  start-page: 1
  year: 2013
  end-page: 18
  ident: CR70
  article-title: Nanoparticles for brain drug delivery
  publication-title: ISRN Biochem
– volume: 14
  start-page: 024044
  issue: 2
  year: 2009
  ident: CR97
  article-title: Near-infrared narrow-band imaging of gold/silica nanoshells in tumors
  publication-title: J Biomed Opt
– volume: 7
  start-page: 39
  issue: 1
  year: 2010
  ident: CR80
  article-title: The nanosilica hazard: another variable entity
  publication-title: Part Fibre Toxicol
– ident: CR148
– volume: 36
  start-page: 6
  issue: 1
  year: 2010
  end-page: 15
  ident: CR119
  article-title: The use of fluorescent dyes and probes in surgical oncology
  publication-title: Eur J Surg Oncol
– volume: 329
  start-page: 88
  issue: 1–2
  year: 2007
  end-page: 93
  ident: CR43
  article-title: Doxorubicin skin penetration from monoolein-containing propylene glycol formulations
  publication-title: Int J Pharm
– volume: 41
  start-page: 2545
  issue: 7
  year: 2012
  end-page: 2561
  ident: CR30
  article-title: Design of polymeric nanoparticles for biomedical delivery applications
  publication-title: Chem Soc Rev
– volume: 24
  start-page: 1211
  issue: 10
  year: 2006
  end-page: 1217
  ident: CR128
  article-title: The emerging nanomedicine landscape
  publication-title: Nat Biotechnol
– volume: 16
  start-page: 1450
  issue: 8
  year: 2008
  end-page: 1458
  ident: CR78
  article-title: Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers
  publication-title: Mol Ther
– ident: CR154
– volume: 10
  start-page: 2199
  issue: 6
  year: 2013
  end-page: 2210
  ident: CR57
  article-title: Dexamethasone-loaded block copolymer nanoparticles induce leukemia cell death and enhance therapeutic efficacy: a novel application in pediatric nanomedicine
  publication-title: Mol Pharm
– volume: 19
  start-page: 129
  issue: 3
  year: 2011
  end-page: 141
  ident: CR76
  article-title: Nanoparticles: emerging carriers for drug delivery
  publication-title: Saudi Pharm J
– volume: 21
  start-page: 285103
  issue: 28
  year: 2010
  ident: CR41
  article-title: Lung deposition and extrapulmonary translocation of nano-ceria after intratracheal instillation
  publication-title: Nanotechnology
– volume: 27
  start-page: 6971
  issue: 11
  year: 2011
  end-page: 6976
  ident: CR130
  article-title: Aptamer-conjugated nanobubbles for targeted ultrasound molecular imaging
  publication-title: Langmuir
– volume: 153
  start-page: 198
  issue: 3
  year: 2011
  end-page: 205
  ident: CR9
  article-title: Targeted drug delivery to tumors: myths, reality and possibility
  publication-title: J Control Release
– volume: 18
  start-page: 17
  issue: 1
  year: 2007
  end-page: 25
  ident: CR99
  article-title: Fluorescence imaging in vivo: recent advances
  publication-title: Curr Opin Biotechnol
– year: 2013
  ident: CR120
  article-title: Nanooncology: the future of cancer diagnosis and therapy
  publication-title: CA Cancer J Clin
– volume: 102
  start-page: 1281
  issue: 4
  year: 2013
  end-page: 1289
  ident: CR77
  article-title: Surface modification of liposomes using polymer-wheat germ agglutinin conjugates to improve the absorption of peptide drugs by pulmonary administration
  publication-title: J Pharm Sci
– volume: 100
  start-page: 704
  issue: 2
  year: 2011
  end-page: 714
  ident: CR95
  article-title: Controlled drug delivery system based on ordered mesoporous silica matrices of captopril as angiotensin-converting enzyme inhibitor drug
  publication-title: J Pharm Sci
– volume: 6
  start-page: 1343
  issue: 9
  year: 2009
  end-page: 1349
  ident: CR28
  article-title: Adsorption of the Pt(II) anticancer drug carboplatin by mesoporous silica
  publication-title: Chem Biodivers
– volume: 150
  start-page: 552
  issue: 5
  year: 2007
  end-page: 558
  ident: CR71
  article-title: Nanoparticles: pharmacological and toxicological significance
  publication-title: Br J Pharmacol
– volume: 40
  start-page: 1380
  issue: 7
  year: 2012
  end-page: 1388
  ident: CR54
  article-title: Nano-advantage in enhanced drug delivery with biodegradable nanoparticles: contribution of reduced clearance
  publication-title: Drug Metab Dispos Biol Fate Chem
– volume: 436
  start-page: 568
  issue: 7050
  year: 2005
  end-page: 572
  ident: CR107
  article-title: Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system
  publication-title: Nature
– volume: 201–202
  start-page: 18
  year: 2013
  end-page: 29
  ident: CR103
  article-title: Exocytosis of nanoparticles from cells: role in cellular retention and toxicity
  publication-title: Adv Colloid Interface Sci
– volume: 7
  start-page: 266
  issue: 5
  year: 2010
  end-page: 276
  ident: CR106
  article-title: Conscripts of the infinite armada: systemic cancer therapy using nanomaterials
  publication-title: Nat Rev Clin Voncol
– volume: 2
  start-page: 289
  issue: 3
  year: 2007
  end-page: 300
  ident: CR127
  article-title: Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives
  publication-title: Int J Nanomed
– volume: 4
  start-page: 399
  issue: 5
  year: 2009
  end-page: 413
  ident: CR44
  article-title: Molecular imaging and therapy of cancer with radiolabeled nanoparticles
  publication-title: Nano today
– volume: 25
  start-page: 4127
  issue: 12
  year: 2011
  end-page: 4137
  ident: CR35
  article-title: Phosphorylated alpha-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson’s disease
  publication-title: FASEB J
– volume: 2
  start-page: 147
  year: 2007
  end-page: 157
  ident: CR39
  article-title: Polymeric nanoparticles, nanospheres and nanocapsules, for cutaneous applications
  publication-title: Drug target insights
– volume: 3
  start-page: 1377
  issue: 3
  year: 2011
  end-page: 1397
  ident: CR68
  article-title: Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier
  publication-title: Polymers
– volume: 2
  start-page: 108
  issue: 1
  year: 2005
  end-page: 119
  ident: CR81
  article-title: Drug transport to brain with targeted nanoparticles
  publication-title: NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics
– volume: 54
  start-page: 124
  issue: 1
  year: 2011
  end-page: 135
  ident: CR90
  article-title: Conformation parameters of linear macromolecules from velocity sedimentation and other hydrodynamic methods
  publication-title: Methods
– volume: 1
  start-page: 297
  issue: 3
  year: 2006
  end-page: 315
  ident: CR49
  article-title: Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential
  publication-title: Int J Nanomed
– volume: 128
  start-page: 679
  issue: 3
  year: 2011
  end-page: 689
  ident: CR73
  article-title: Image-guided tumor resection using real-time near-infrared fluorescence in a syngeneic rat model of primary breast cancer
  publication-title: Breast Cancer Res Treat
– volume: 17
  start-page: 2950
  issue: 8
  year: 2009
  end-page: 2962
  ident: CR32
  article-title: Nanoparticles in cellular drug delivery
  publication-title: Bioorg Med Chem
– volume: 71
  start-page: 409
  issue: 3
  year: 2009
  end-page: 419
  ident: CR66
  article-title: Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect
  publication-title: Eur J Pharm Biopharm
– volume: 342
  start-page: 607
  issue: 2
  year: 2010
  end-page: 613
  ident: CR60
  article-title: Organically modified MCM-type material preparation and its usage in controlled amoxicillin delivery
  publication-title: J Colloid Interface Sci
– volume: 7
  start-page: e31875
  issue: 2
  year: 2012
  ident: CR136
  article-title: Dual-wavelength imaging of tumor progression by activatable and targeting near-infrared fluorescent probes in a bioluminescent breast cancer model
  publication-title: PLoS One
– volume: 3
  start-page: 133
  issue: 2
  year: 2008
  end-page: 149
  ident: CR26
  article-title: Drug delivery and nanoparticles: applications and hazards
  publication-title: Int J Nanomed
– volume: 242
  start-page: 66
  issue: 1
  year: 2010
  end-page: 78
  ident: CR52
  article-title: Evaluating the uptake and intracellular fate of polystyrene nanoparticles by primary and hepatocyte cell lines in vitro
  publication-title: Toxicol Appl Pharmacol
– volume: 6
  start-page: 865
  issue: 8
  year: 2009
  end-page: 878
  ident: CR37
  article-title: Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy
  publication-title: Expert Opin Drug Deliv
– volume: 145
  start-page: 182
  issue: 3
  year: 2010
  end-page: 195
  ident: CR102
  article-title: Endocytosis of nanomedicines
  publication-title: J Control Release
– volume: 23
  start-page: H18
  issue: 12
  year: 2011
  end-page: H40
  ident: CR12
  article-title: Nanomaterials: applications in cancer imaging and therapy
  publication-title: Adv Mater
– volume: 1
  start-page: 375
  issue: 4
  year: 2006
  end-page: 383
  ident: CR21
  article-title: Biological and clinical characterization of paclitaxel poliglumex (PPX, CT-2103), a macromolecular polymer-drug conjugate
  publication-title: Int J Nanomed
– ident: CR143
– volume: 101
  start-page: 122
  issue: 1
  year: 2008
  end-page: 131
  ident: CR10
  article-title: Inhalation toxicity and lung toxicokinetics of C60 fullerene nanoparticles and microparticles
  publication-title: Toxicol Sci
– volume: 9
  start-page: 421
  issue: 4
  year: 2007
  end-page: 433
  ident: CR86
  article-title: In vitro and in vivo evaluation of Bola-surfactant containing niosomes for transdermal delivery
  publication-title: Biomed Microdevices
– volume: 123
  start-page: 576
  issue: 2
  year: 2011
  end-page: 589
  ident: CR110
  article-title: Fullerene c60: inhalation hazard assessment and derivation of a period-limited acceptable exposure level
  publication-title: Toxicol Sci
– volume: 9
  start-page: 929
  issue: 12
  year: 2008
  end-page: 943
  ident: CR34
  article-title: Fluorescent probes for super-resolution imaging in living cells
  publication-title: Nat Rev Mol Cell Biol
– volume: 108
  start-page: 6656
  issue: 16
  year: 2011
  end-page: 6661
  ident: CR24
  article-title: Targeting kidney mesangium by nanoparticles of defined size
  publication-title: Proc Natl Acad Sci USA
– volume: 16
  start-page: 361
  issue: 8
  year: 2007
  end-page: 374
  ident: CR40
  article-title: Increased preclinical efficacy of irinotecan and floxuridine coencapsulated inside liposomes is associated with tumor delivery of synergistic drug ratios
  publication-title: Oncol Res
– volume: 624
  start-page: 249
  year: 2010
  end-page: 265
  ident: CR58
  article-title: Targeting of nanoparticles: folate receptor
  publication-title: Methods Mol Biol
– ident: CR152
– volume: 41
  start-page: 1578
  issue: 12
  year: 2008
  end-page: 1586
  ident: CR50
  article-title: Noble metals on the nanoscale: optical and photothermal properties and some applications in imaging, sensing, biology, and medicine
  publication-title: Acc Chem Res
– volume: 3
  start-page: 703
  issue: 5
  year: 2008
  end-page: 717
  ident: CR64
  article-title: Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats
  publication-title: Nanomedicine (Lond)
– volume: 16
  start-page: 154
  issue: 1
  year: 2008
  end-page: 162
  ident: CR135
  article-title: Fully detargeted polyethylene glycol-coated adenovirus vectors are potent genetic vaccines and escape from pre-existing anti-adenovirus antibodies
  publication-title: Mol Ther
– volume: 239
  start-page: 106
  issue: 1
  year: 2009
  end-page: 115
  ident: CR22
  article-title: Pulmonary toxicity and kinetic study of Cy5.5-conjugated superparamagnetic iron oxide nanoparticles by optical imaging
  publication-title: Toxicol Appl Pharmacol
– volume: 18
  start-page: 1498
  issue: 5
  year: 2007
  end-page: 1506
  ident: CR13
  article-title: A macrophage-nanozyme delivery system for Parkinson’s disease
  publication-title: Bioconjugate chemistry
– ident: CR146
– volume: 1
  start-page: 323
  issue: 2
  year: 2010
  end-page: 334
  ident: CR47
  article-title: Nanoparticle-assisted combination therapies for effective cancer treatment
  publication-title: Ther Deliv
– ident: CR149
– volume: 5
  start-page: 162
  issue: 2
  year: 2009
  end-page: 169
  ident: CR101
  article-title: Protracted elimination of gold nanoparticles from mouse liver
  publication-title: Nanomed Nanotechnol Biol Med
– volume: 30
  start-page: 3476
  issue: 20
  year: 2009
  end-page: 3485
  ident: CR126
  article-title: The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation
  publication-title: Biomaterials
– volume: 33
  start-page: 2230
  issue: 7
  year: 2012
  end-page: 2239
  ident: CR117
  article-title: A NIR heptamethine dye with intrinsic cancer targeting, imaging and photosensitizing properties
  publication-title: Biomaterials
– volume: 66
  start-page: 2
  year: 2014
  end-page: 25
  ident: CR15
  article-title: Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology
  publication-title: Adv Drug Deliv Rev
– ident: CR155
– volume: 8
  start-page: 1121
  year: 2013
  end-page: 1128
  ident: CR124
  article-title: Subacute toxicity of cadmium on hepatocytes and nephrocytes in the rat could be considered as a green biosynthesis of nanoparticles
  publication-title: Int J Nanomed
– volume: 12
  start-page: 4591
  issue: 7
  year: 2011
  end-page: 4608
  ident: CR116
  article-title: Enhanced anti-tumoral activity of methotrexate-human serum albumin conjugated nanoparticles by targeting with luteinizing hormone-releasing hormone (LHRH) peptide
  publication-title: Int J Mol Sci
– volume: 49
  start-page: 6087
  issue: 20
  year: 2006
  end-page: 6093
  ident: CR74
  article-title: Multivalent effects of RGD peptides obtained by nanoparticle display
  publication-title: J Med Chem
– volume: 4
  start-page: 145
  issue: 2
  year: 2005
  end-page: 160
  ident: CR121
  article-title: Recent advances with liposomes as pharmaceutical carriers
  publication-title: Nat Rev Drug Discov
– volume: 27
  start-page: 3482
  issue: 18
  year: 2006
  end-page: 3490
  ident: CR36
  article-title: Lectin-conjugated PEG–PLA nanoparticles: preparation and brain delivery after intranasal administration
  publication-title: Biomaterials
– volume: 319
  start-page: 155
  issue: 1–2
  year: 2006
  end-page: 161
  ident: CR7
  article-title: Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles
  publication-title: Int J Pharm
– volume: 15
  start-page: 485
  issue: 8
  year: 2008
  end-page: 492
  ident: CR25
  article-title: Preparation and characterization of silica xerogels as carriers for drugs
  publication-title: Drug Deliv
– volume: 20
  start-page: 2212
  issue: 17
  year: 2013
  end-page: 2225
  ident: CR123
  article-title: Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier
  publication-title: Curr Med Chem
– volume: 2011
  start-page: 469679
  year: 2011
  ident: CR114
  article-title: Liposomes for targeted delivery of active agents against neurodegenerative diseases (Alzheimer’s disease and Parkinson’s disease)
  publication-title: J Drug Deliv
– volume: 8
  start-page: 2812
  issue: 3
  year: 2014
  end-page: 2819
  ident: CR141
  article-title: Optimized metal-organic-framework nanospheres for drug delivery: evaluation of small-molecule encapsulation
  publication-title: ACS Nano
– volume: 1
  start-page: 35
  issue: 1
  year: 2011
  end-page: 40
  ident: CR129
  article-title: Superparamagnetic iron oxide based MRI contrast agents: current status of clinical application
  publication-title: Quant Imaging Med Surg
– volume: 73
  start-page: 90
  issue: 1
  year: 2009
  end-page: 94
  ident: CR111
  article-title: Assessment of the percutaneous penetration of cisplatin: the effect of monoolein and the drug skin penetration pathway
  publication-title: Eur J Pharm Biopharm
– volume: 31
  start-page: 8198
  issue: 32
  year: 2010
  end-page: 8209
  ident: CR62
  article-title: Endothelial cells dysfunction induced by silica nanoparticles through oxidative stress via JNK/P53 and NF-kappaB pathways
  publication-title: Biomaterials
– volume: 14
  start-page: 1
  year: 2012
  end-page: 16
  ident: CR3
  article-title: The effect of nanoparticle size, shape, and surface chemistry on biological systems
  publication-title: Annu Rev Biomed Eng
– volume: 55
  start-page: 23
  issue: 1
  year: 2014
  end-page: 29
  ident: CR75
  article-title: Functional imaging of human epidermal growth factor receptor 2-positive metastatic breast cancer using (64)Cu-DOTA-trastuzumab PET
  publication-title: J Nucl Med
– volume: 61
  start-page: 158
  issue: 2
  year: 2009
  end-page: 171
  ident: CR59
  article-title: Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
  publication-title: Adv Drug Deliv Rev
– volume: 83
  start-page: 761
  issue: 5
  year: 2008
  end-page: 769
  ident: CR137
  article-title: Nanoparticles in medicine: therapeutic applications and developments
  publication-title: Clin Pharmacol Ther
– volume: 33
  start-page: 113
  issue: 1
  year: 2008
  end-page: 137
  ident: CR89
  article-title: Polymeric nanomedicine for cancer therapy
  publication-title: Prog Polym Sci
– volume: 7
  start-page: 1919
  issue: 14
  year: 2011
  ident: 2527_CR131
  publication-title: Small
  doi: 10.1002/smll.201100442
– volume: 18
  start-page: 17
  issue: 1
  year: 2007
  ident: 2527_CR99
  publication-title: Curr Opin Biotechnol
  doi: 10.1016/j.copbio.2007.01.003
– volume: 18
  start-page: 8440
  issue: 7
  year: 2013
  ident: 2527_CR104
  publication-title: Molecules
  doi: 10.3390/molecules18078440
– volume: 150
  start-page: 552
  issue: 5
  year: 2007
  ident: 2527_CR71
  publication-title: Br J Pharmacol
  doi: 10.1038/sj.bjp.0707130
– volume: 16
  start-page: 361
  issue: 8
  year: 2007
  ident: 2527_CR40
  publication-title: Oncol Res
  doi: 10.3727/000000006783980937
– volume: 6
  start-page: 1430
  issue: 7
  year: 2009
  ident: 2527_CR67
  publication-title: J Comput Theor Nanosci
  doi: 10.1166/jctn.2009.1189
– volume: 2
  start-page: 289
  issue: 3
  year: 2007
  ident: 2527_CR127
  publication-title: Int J Nanomed
– volume: 31
  start-page: 3236
  year: 2007
  ident: 2527_CR125
  publication-title: Chem Commun (Camb)
  doi: 10.1039/b701744h
– volume: 2
  start-page: 147
  year: 2007
  ident: 2527_CR39
  publication-title: Drug target insights
  doi: 10.1177/117739280700200002
– ident: 2527_CR150
  doi: 10.1007/s12272-011-0220-2
– volume: 16
  start-page: 154
  issue: 1
  year: 2008
  ident: 2527_CR135
  publication-title: Mol Ther
  doi: 10.1038/sj.mt.6300306
– volume: 29
  start-page: 624
  issue: 12
  year: 2011
  ident: 2527_CR8
  publication-title: Trends Biotechnol
  doi: 10.1016/j.tibtech.2011.06.010
– volume: 22
  start-page: 3570
  issue: 8
  year: 2006
  ident: 2527_CR105
  publication-title: Langmuir
  doi: 10.1021/la0531998
– volume: 15
  start-page: 485
  issue: 8
  year: 2008
  ident: 2527_CR25
  publication-title: Drug Deliv
  doi: 10.1080/10717540802321495
– volume: 22
  start-page: 99
  issue: 1
  year: 2008
  ident: 2527_CR56
  publication-title: Br J Neurosurg
  doi: 10.1080/02688690701765524
– volume: 5
  start-page: 162
  issue: 2
  year: 2009
  ident: 2527_CR101
  publication-title: Nanomed Nanotechnol Biol Med
  doi: 10.1016/j.nano.2008.11.002
– volume: 46
  start-page: 761
  issue: 3
  year: 2013
  ident: 2527_CR132
  publication-title: Acc Chem Res
  doi: 10.1021/ar2003336
– ident: 2527_CR156
  doi: 10.1016/j.jconrel.2012.10.007
– ident: 2527_CR142
  doi: 10.1021/nn901025x
– volume: 8
  start-page: 2812
  issue: 3
  year: 2014
  ident: 2527_CR141
  publication-title: ACS Nano
  doi: 10.1021/nn406590q
– volume: 101
  start-page: 122
  issue: 1
  year: 2008
  ident: 2527_CR10
  publication-title: Toxicol Sci
  doi: 10.1093/toxsci/kfm243
– volume: 7
  start-page: 39
  issue: 1
  year: 2010
  ident: 2527_CR80
  publication-title: Part Fibre Toxicol
  doi: 10.1186/1743-8977-7-39
– volume: 12
  start-page: 4591
  issue: 7
  year: 2011
  ident: 2527_CR116
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms12074591
– volume: 40
  start-page: 1380
  issue: 7
  year: 2012
  ident: 2527_CR54
  publication-title: Drug Metab Dispos Biol Fate Chem
  doi: 10.1124/dmd.112.044925
– volume: 20
  start-page: 222
  issue: 4
  year: 2013
  ident: 2527_CR18
  publication-title: Cancer Gene Ther
  doi: 10.1038/cgt.2013.9
– volume: 5
  start-page: 505
  issue: 4
  year: 2008
  ident: 2527_CR4
  publication-title: Mol Pharm
  doi: 10.1021/mp800051m
– ident: 2527_CR155
  doi: 10.1016/j.jconrel.2004.04.026
– volume: 6
  start-page: 1343
  issue: 9
  year: 2009
  ident: 2527_CR28
  publication-title: Chem Biodivers
  doi: 10.1002/cbdv.200900021
– volume: 85
  start-page: 227
  issue: 4
  year: 2005
  ident: 2527_CR85
  publication-title: Tuberculosis (Edinb)
  doi: 10.1016/j.tube.2004.11.003
– volume: 353
  start-page: 233
  issue: 1–2
  year: 2008
  ident: 2527_CR87
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2007.11.037
– volume: 33
  start-page: 113
  issue: 1
  year: 2008
  ident: 2527_CR89
  publication-title: Prog Polym Sci
  doi: 10.1016/j.progpolymsci.2007.09.003
– volume: 1
  start-page: 375
  issue: 4
  year: 2006
  ident: 2527_CR21
  publication-title: Int J Nanomed
  doi: 10.2147/nano.2006.1.4.375
– volume: 4
  start-page: 10
  year: 2007
  ident: 2527_CR100
  publication-title: Part Fibre Toxicol
  doi: 10.1186/1743-8977-4-10
– volume: 20
  start-page: 2212
  issue: 17
  year: 2013
  ident: 2527_CR123
  publication-title: Curr Med Chem
  doi: 10.2174/0929867311320170006
– volume: 1
  start-page: 35
  issue: 1
  year: 2011
  ident: 2527_CR129
  publication-title: Quant Imaging Med Surg
– volume: 64
  start-page: 1020
  issue: 5
  year: 2012
  ident: 2527_CR133
  publication-title: Pharmacol Rep
  doi: 10.1016/S1734-1140(12)70901-5
– volume: 26
  start-page: 1261
  issue: 11
  year: 2008
  ident: 2527_CR96
  publication-title: Nat Biotechnol
  doi: 10.1038/nbt.1504
– volume: 27
  start-page: 3482
  issue: 18
  year: 2006
  ident: 2527_CR36
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2006.01.038
– volume: 9
  start-page: E128
  issue: 2
  year: 2007
  ident: 2527_CR122
  publication-title: AAPS J
  doi: 10.1208/aapsj0902015
– volume: 102
  start-page: 1281
  issue: 4
  year: 2013
  ident: 2527_CR77
  publication-title: J Pharm Sci
  doi: 10.1002/jps.23463
– volume: 23
  start-page: H18
  issue: 12
  year: 2011
  ident: 2527_CR12
  publication-title: Adv Mater
  doi: 10.1002/adma.201100140
– volume: 57
  start-page: 2106
  issue: 15
  year: 2005
  ident: 2527_CR115
  publication-title: Adv Drug Deliv Rev
  doi: 10.1016/j.addr.2005.09.018
– volume: 8
  start-page: e63159
  issue: 5
  year: 2013
  ident: 2527_CR139
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0063159
– volume: 41
  start-page: 2971
  issue: 7
  year: 2012
  ident: 2527_CR55
  publication-title: Chem Soc Rev
  doi: 10.1039/c2cs15344k
– ident: 2527_CR145
  doi: 10.1038/nature08956
– volume: 33
  start-page: 2230
  issue: 7
  year: 2012
  ident: 2527_CR117
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2011.11.081
– volume: 107
  start-page: 342
  issue: 2
  year: 2009
  ident: 2527_CR140
  publication-title: Toxicol Sci
  doi: 10.1093/toxsci/kfn245
– volume: 31
  start-page: 6612
  issue: 25
  year: 2010
  ident: 2527_CR138
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2010.05.007
– volume: 66
  start-page: 2
  year: 2014
  ident: 2527_CR15
  publication-title: Adv Drug Deliv Rev
  doi: 10.1016/j.addr.2013.11.009
– volume: 61
  start-page: 158
  issue: 2
  year: 2009
  ident: 2527_CR59
  publication-title: Adv Drug Deliv Rev
  doi: 10.1016/j.addr.2008.11.002
– volume: 24
  start-page: 5213
  issue: 10
  year: 2008
  ident: 2527_CR20
  publication-title: Langmuir
  doi: 10.1021/la703570m
– volume: 372
  start-page: 191
  issue: 1–2
  year: 2009
  ident: 2527_CR65
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2009.01.014
– volume: 60
  start-page: 1278
  issue: 11
  year: 2008
  ident: 2527_CR112
  publication-title: Adv Drug Deliv Rev
  doi: 10.1016/j.addr.2008.03.012
– volume: 63
  start-page: 217
  year: 2012
  ident: 2527_CR108
  publication-title: Annu Rev Med
  doi: 10.1146/annurev-med-070910-083323
– volume: 16
  start-page: 1450
  issue: 8
  year: 2008
  ident: 2527_CR78
  publication-title: Mol Ther
  doi: 10.1038/mt.2008.127
– volume: 329
  start-page: 88
  issue: 1–2
  year: 2007
  ident: 2527_CR43
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2006.08.021
– volume: 41
  start-page: 1578
  issue: 12
  year: 2008
  ident: 2527_CR50
  publication-title: Acc Chem Res
  doi: 10.1021/ar7002804
– volume: 19
  start-page: 1496
  issue: 7
  year: 2008
  ident: 2527_CR51
  publication-title: Bioconjug Chem
  doi: 10.1021/bc800108v
– volume: 50
  start-page: 5860
  issue: 26
  year: 2011
  ident: 2527_CR61
  publication-title: Angew Chem
  doi: 10.1002/anie.201008206
– volume: 2012
  start-page: 940585
  year: 2012
  ident: 2527_CR2
  publication-title: Int J Biomed Imaging
  doi: 10.1155/2012/940585
– volume: 342
  start-page: 607
  issue: 2
  year: 2010
  ident: 2527_CR60
  publication-title: J Colloid Interface Sci
  doi: 10.1016/j.jcis.2009.10.073
– volume: 73
  start-page: 90
  issue: 1
  year: 2009
  ident: 2527_CR111
  publication-title: Eur J Pharm Biopharm
  doi: 10.1016/j.ejpb.2009.04.016
– volume: 7
  start-page: e31875
  issue: 2
  year: 2012
  ident: 2527_CR136
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0031875
– volume: 3
  start-page: 703
  issue: 5
  year: 2008
  ident: 2527_CR64
  publication-title: Nanomedicine (Lond)
  doi: 10.2217/17435889.3.5.703
– ident: 2527_CR148
  doi: 10.1517/17425247.2010.492212
– volume: 201–202
  start-page: 18
  year: 2013
  ident: 2527_CR103
  publication-title: Adv Colloid Interface Sci
  doi: 10.1016/j.cis.2013.10.013
– volume: 16
  start-page: 1503
  issue: 6
  year: 2005
  ident: 2527_CR1
  publication-title: Bioconjug Chem
  doi: 10.1021/bc050217o
– volume: 215
  start-page: 119
  issue: 2
  year: 2012
  ident: 2527_CR83
  publication-title: Toxicol Lett
  doi: 10.1016/j.toxlet.2012.09.025
– volume: 9
  start-page: 2255
  issue: 8
  year: 2010
  ident: 2527_CR16
  publication-title: Mol Cancer Ther
  doi: 10.1158/1535-7163.MCT-10-0172
– volume: 128
  start-page: 679
  issue: 3
  year: 2011
  ident: 2527_CR73
  publication-title: Breast Cancer Res Treat
  doi: 10.1007/s10549-010-1130-6
– volume: 3
  start-page: 89
  issue: 1
  year: 2011
  ident: 2527_CR109
  publication-title: J Pharm Bioallied Sci
  doi: 10.4103/0975-7406.76478
– volume: 9
  start-page: 421
  issue: 4
  year: 2007
  ident: 2527_CR86
  publication-title: Biomed Microdevices
  doi: 10.1007/s10544-007-9046-6
– volume: 55
  start-page: 23
  issue: 1
  year: 2014
  ident: 2527_CR75
  publication-title: J Nucl Med
  doi: 10.2967/jnumed.113.122630
– volume: 31
  start-page: 8198
  issue: 32
  year: 2010
  ident: 2527_CR62
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2010.07.069
– volume: 160
  start-page: 1
  issue: 1
  year: 2012
  ident: 2527_CR88
  publication-title: J Control Release
  doi: 10.1016/j.jconrel.2012.05.016
– volume: 9
  start-page: 615
  issue: 8
  year: 2010
  ident: 2527_CR92
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/nrd2591
– volume: 436
  start-page: 568
  issue: 7050
  year: 2005
  ident: 2527_CR107
  publication-title: Nature
  doi: 10.1038/nature03794
– volume: 319
  start-page: 155
  issue: 1–2
  year: 2006
  ident: 2527_CR7
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2006.03.052
– volume: 30
  start-page: 3476
  issue: 20
  year: 2009
  ident: 2527_CR126
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2009.03.010
– volume: 153
  start-page: 198
  issue: 3
  year: 2011
  ident: 2527_CR9
  publication-title: J Control Release
  doi: 10.1016/j.jconrel.2011.06.001
– volume: 141
  start-page: 320
  issue: 3
  year: 2010
  ident: 2527_CR27
  publication-title: J Control Release
  doi: 10.1016/j.jconrel.2009.10.014
– volume: 24
  start-page: 1211
  issue: 10
  year: 2006
  ident: 2527_CR128
  publication-title: Nat Biotechnol
  doi: 10.1038/nbt1006-1211
– volume: 108
  start-page: 6656
  issue: 16
  year: 2011
  ident: 2527_CR24
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1103573108
– volume: 100
  start-page: 704
  issue: 2
  year: 2011
  ident: 2527_CR95
  publication-title: J Pharm Sci
  doi: 10.1002/jps.22308
– volume: 624
  start-page: 249
  year: 2010
  ident: 2527_CR58
  publication-title: Methods Mol Biol
  doi: 10.1007/978-1-60761-609-2_17
– volume: 99
  start-page: 2049
  issue: 4
  year: 2010
  ident: 2527_CR14
  publication-title: J Pharm Sci
  doi: 10.1002/jps.21944
– volume: 103
  start-page: 4930
  issue: 13
  year: 2006
  ident: 2527_CR19
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0600997103
– volume: 4
  start-page: 145
  issue: 2
  year: 2005
  ident: 2527_CR121
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/nrd1632
– volume: 3
  start-page: 2804
  year: 2013
  ident: 2527_CR29
  publication-title: Sci Rep
  doi: 10.1038/srep02804
– volume: 6
  start-page: 715
  issue: 4
  year: 2011
  ident: 2527_CR53
  publication-title: Nanomedicine (Lond)
  doi: 10.2217/nnm.11.19
– year: 2013
  ident: 2527_CR120
  publication-title: CA Cancer J Clin
– volume: 11
  start-page: 395
  issue: 3
  year: 2009
  ident: 2527_CR98
  publication-title: AAPS J
  doi: 10.1208/s12248-009-9116-1
– volume: 7
  start-page: 541
  issue: 5
  year: 2011
  ident: 2527_CR118
  publication-title: Nanomed Nanotechnol Biol Med
  doi: 10.1016/j.nano.2011.06.015
– volume: 50
  start-page: 3892
  issue: 11
  year: 2012
  ident: 2527_CR84
  publication-title: Food Chem Toxicol
  doi: 10.1016/j.fct.2012.07.005
– volume: 14
  start-page: 024044
  issue: 2
  year: 2009
  ident: 2527_CR97
  publication-title: J Biomed Opt
  doi: 10.1117/1.3120494
– volume: 24
  start-page: 2099
  issue: 11
  year: 2007
  ident: 2527_CR17
  publication-title: Pharm Res
  doi: 10.1007/s11095-007-9335-z
– volume: 6
  start-page: 321
  issue: 1
  year: 2011
  ident: 2527_CR45
  publication-title: Nanoscale Res Lett
  doi: 10.1186/1556-276X-6-321
– volume: 2
  start-page: 2826
  issue: 12
  year: 2010
  ident: 2527_CR113
  publication-title: Nanoscale
  doi: 10.1039/c0nr00345j
– volume: 117
  start-page: 4812
  issue: 21
  year: 2011
  ident: 2527_CR94
  publication-title: Cancer
  doi: 10.1002/cncr.26087
– volume: 21
  start-page: 285103
  issue: 28
  year: 2010
  ident: 2527_CR41
  publication-title: Nanotechnology
  doi: 10.1088/0957-4484/21/28/285103
– volume: 355
  start-page: 314
  issue: 1–2
  year: 2008
  ident: 2527_CR48
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2007.12.013
– volume: 3
  start-page: 133
  issue: 2
  year: 2008
  ident: 2527_CR26
  publication-title: Int J Nanomed
  doi: 10.2147/IJN.S596
– volume: 6
  start-page: 1041
  issue: 4
  year: 2009
  ident: 2527_CR38
  publication-title: Mol Pharm
  doi: 10.1021/mp900090z
– volume: 65
  start-page: 36
  issue: 1
  year: 2013
  ident: 2527_CR5
  publication-title: Adv Drug Deliv Rev
  doi: 10.1016/j.addr.2012.09.037
– volume: 3
  start-page: 3
  issue: 1
  year: 2011
  ident: 2527_CR11
  publication-title: Vasc Cell
  doi: 10.1186/2045-824X-3-3
– ident: 2527_CR146
  doi: 10.1093/annonc/mdm374
– volume: 6
  start-page: 865
  issue: 8
  year: 2009
  ident: 2527_CR37
  publication-title: Expert Opin Drug Deliv
  doi: 10.1517/17425240902932908
– ident: 2527_CR151
  doi: 10.2147/IJN.S16923
– volume: 2013
  start-page: 1
  year: 2013
  ident: 2527_CR70
  publication-title: ISRN Biochem
  doi: 10.1155/2013/238428
– volume: 2011
  start-page: 469679
  year: 2011
  ident: 2527_CR114
  publication-title: J Drug Deliv
  doi: 10.1155/2011/469679
– volume: 7
  start-page: 27
  year: 2013
  ident: 2527_CR6
  publication-title: Drug target insights
  doi: 10.4137/DTI.S12519
– volume: 7
  start-page: 266
  issue: 5
  year: 2010
  ident: 2527_CR106
  publication-title: Nat Rev Clin Voncol
  doi: 10.1038/nrclinonc.2010.38
– volume: 18
  start-page: 1498
  issue: 5
  year: 2007
  ident: 2527_CR13
  publication-title: Bioconjugate chemistry
  doi: 10.1021/bc700184b
– ident: 2527_CR154
  doi: 10.18433/J3M59P
– ident: 2527_CR143
  doi: 10.1016/j.addr.2009.05.005
– volume: 41
  start-page: 2545
  issue: 7
  year: 2012
  ident: 2527_CR30
  publication-title: Chem Soc Rev
  doi: 10.1039/c2cs15327k
– volume: 49
  start-page: 6087
  issue: 20
  year: 2006
  ident: 2527_CR74
  publication-title: J Med Chem
  doi: 10.1021/jm060515m
– volume: 32
  start-page: 7711
  issue: 30
  year: 2011
  ident: 2527_CR42
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2011.06.066
– volume: 2
  start-page: 108
  issue: 1
  year: 2005
  ident: 2527_CR81
  publication-title: NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics
  doi: 10.1602/neurorx.2.1.108
– volume: 18
  start-page: 25
  issue: Suppl 5
  year: 2012
  ident: 2527_CR93
  publication-title: Clin Microbiol Infect
  doi: 10.1111/j.1469-0691.2012.03938.x
– volume: 1
  start-page: 297
  issue: 3
  year: 2006
  ident: 2527_CR49
  publication-title: Int J Nanomed
  doi: 10.2217/17435889.1.3.297
– volume: 242
  start-page: 66
  issue: 1
  year: 2010
  ident: 2527_CR52
  publication-title: Toxicol Appl Pharmacol
  doi: 10.1016/j.taap.2009.09.015
– ident: 2527_CR147
  doi: 10.1021/ar2000138
– volume: 3
  start-page: 1377
  issue: 3
  year: 2011
  ident: 2527_CR68
  publication-title: Polymers
  doi: 10.3390/polym3031377
– volume: 14
  start-page: 1
  year: 2012
  ident: 2527_CR3
  publication-title: Annu Rev Biomed Eng
  doi: 10.1146/annurev-bioeng-071811-150124
– volume: 394
  start-page: 115
  issue: 1–2
  year: 2010
  ident: 2527_CR46
  publication-title: Int J Pharm
– volume: 239
  start-page: 106
  issue: 1
  year: 2009
  ident: 2527_CR22
  publication-title: Toxicol Appl Pharmacol
  doi: 10.1016/j.taap.2009.05.026
– volume: 11
  start-page: 282
  issue: 5
  year: 2014
  ident: 2527_CR134
  publication-title: Nat Rev Clin Oncol
  doi: 10.1038/nrclinonc.2014.51
– volume: 49
  start-page: 205
  year: 1965
  ident: 2527_CR33
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjo.49.4.205
– volume: 10
  start-page: 2199
  issue: 6
  year: 2013
  ident: 2527_CR57
  publication-title: Mol Pharm
  doi: 10.1021/mp300350e
– volume: 23
  start-page: 1326
  issue: 7
  year: 2009
  ident: 2527_CR31
  publication-title: Toxicol In Vitro
  doi: 10.1016/j.tiv.2009.07.010
– volume: 25
  start-page: 4127
  issue: 12
  year: 2011
  ident: 2527_CR35
  publication-title: FASEB J
  doi: 10.1096/fj.10-179192
– ident: 2527_CR149
  doi: 10.1016/j.jaad.2011.10.031
– volume: 1
  start-page: 6
  issue: 1
  year: 2009
  ident: 2527_CR63
  publication-title: J Mol Cell Biol
  doi: 10.1093/jmcb/mjp006
– volume: 19
  start-page: 129
  issue: 3
  year: 2011
  ident: 2527_CR76
  publication-title: Saudi Pharm J
  doi: 10.1016/j.jsps.2011.04.001
– volume: 1
  start-page: 323
  issue: 2
  year: 2010
  ident: 2527_CR47
  publication-title: Ther Deliv
  doi: 10.4155/tde.10.13
– volume: 17
  start-page: 2950
  issue: 8
  year: 2009
  ident: 2527_CR32
  publication-title: Bioorg Med Chem
  doi: 10.1016/j.bmc.2009.02.043
– volume: 8
  start-page: 1121
  year: 2013
  ident: 2527_CR124
  publication-title: Int J Nanomed
  doi: 10.2147/IJN.S39426
– ident: 2527_CR144
  doi: 10.1021/mp900015y
– volume: 145
  start-page: 182
  issue: 3
  year: 2010
  ident: 2527_CR102
  publication-title: J Control Release
  doi: 10.1016/j.jconrel.2010.01.036
– volume: 9
  start-page: 929
  issue: 12
  year: 2008
  ident: 2527_CR34
  publication-title: Nat Rev Mol Cell Biol
  doi: 10.1038/nrm2531
– volume: 83
  start-page: 761
  issue: 5
  year: 2008
  ident: 2527_CR137
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/sj.clpt.6100400
– volume: 27
  start-page: 6971
  issue: 11
  year: 2011
  ident: 2527_CR130
  publication-title: Langmuir
  doi: 10.1021/la2011259
– ident: 2527_CR152
  doi: 10.3109/07357900903179591
– volume: 36
  start-page: 6
  issue: 1
  year: 2010
  ident: 2527_CR119
  publication-title: Eur J Surg Oncol
  doi: 10.1016/j.ejso.2009.10.014
– volume: 4
  start-page: 399
  issue: 5
  year: 2009
  ident: 2527_CR44
  publication-title: Nano today
  doi: 10.1016/j.nantod.2009.07.001
– volume: 69
  start-page: 1692
  issue: 12
  year: 2011
  ident: 2527_CR69
  publication-title: Appl Radiat Isot
  doi: 10.1016/j.apradiso.2011.05.002
– volume: 25
  start-page: 1165
  issue: 10
  year: 2007
  ident: 2527_CR23
  publication-title: Nat Biotechnol
  doi: 10.1038/nbt1340
– volume: 6
  start-page: 1685
  year: 2011
  ident: 2527_CR79
  publication-title: Int J Nanomed
– volume: 54
  start-page: 124
  issue: 1
  year: 2011
  ident: 2527_CR90
  publication-title: Methods
  doi: 10.1016/j.ymeth.2011.02.005
– volume: 17
  start-page: 5564
  issue: 5
  year: 2012
  ident: 2527_CR72
  publication-title: Molecules
  doi: 10.3390/molecules17055564
– volume: 337
  start-page: 346
  issue: 1–2
  year: 2007
  ident: 2527_CR91
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2007.01.031
– volume: 307
  start-page: 93
  issue: 1
  year: 2006
  ident: 2527_CR82
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2005.10.010
– ident: 2527_CR153
  doi: 10.1021/ja802318f
– volume: 123
  start-page: 576
  issue: 2
  year: 2011
  ident: 2527_CR110
  publication-title: Toxicol Sci
  doi: 10.1093/toxsci/kfr192
– volume: 71
  start-page: 409
  issue: 3
  year: 2009
  ident: 2527_CR66
  publication-title: Eur J Pharm Biopharm
  doi: 10.1016/j.ejpb.2008.11.010
SSID ssj0016292
Score 2.3239095
SecondaryResourceType review_article
Snippet The ever-increasing number of diseases worldwide requires comprehensive, efficient, and cost-effective modes of treatments. Among various strategies,...
SourceID proquest
pascalfrancis
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1
SubjectTerms Biodegradation
Biological and medical sciences
Biotechnology
Characterization and Evaluation of Materials
Chemistry and Materials Science
Cross-disciplinary physics: materials science; rheology
Diseases
Drug delivery systems
Exact sciences and technology
Fundamental and applied biological sciences. Psychology
General equipment and techniques
Human body
Inorganic Chemistry
Instruments, apparatus, components and techniques common to several branches of physics and astronomy
Journeys
Lasers
Materials Science
Medical services
Methods. Procedures. Technologies
Nanocrystalline materials
Nanomaterials
Nanoparticles
Nanoscale materials and structures: fabrication and characterization
Nanostructure
Nanotechnology
Optical Devices
Optics
Others
Photonics
Physical Chemistry
Physical properties
Physicochemical properties
Physics
Review
Sensors (chemical, optical, electrical, movement, gas, etc.); remote sensing
Side effects
Various methods and equipments
SummonAdditionalLinks – databaseName: SpringerLink Journals (ICM)
  dbid: U2A
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9RAEB9qi2AR0dPS07asIH3QBjab_cj5VkpLEdQ-9KBvYTe7KwVNjiZXvf_e2U1yH6IFH5OdXUJmdvc3zMxvAN6VaUhhYj5RGt1VLrVNcsFUYpy0yuGNm8dwwecv8nLKP92Im76Ouxmy3YeQZDypV8VuCAWC68sTFlZTj2BHBNcdjXjKTpehA8liJ-Q0QxNAJ50Pocy_LbFxGT2d6Qb_i-8aWmwgzj-CpPHuuXgOz3rQSE47Lb-ALVeNYHeNSnAEx1cdB_XihFyvSqqaE3JMrlbs1IsRPI45n2XzEn58vQ8HhftJak8qXdWJvZt_a0i5yeFMENaSoYCSrAW8PxIEjyQao1uQUKcSX8RWJaStu4dfty2Z1bdV-wqmF-fXZ5dJ330hKTkXbSInubKp8BPjBDdcGGW4tX5CS29E7nDEC69EqVKjVVZqY3ErC-2ZQciBuCbbg-2qrtw-EI5uj9PKcyMUp5ZOvNci09RJZVJN7RjooIai7KnJQ4eM78WKVDlorkDNFUFzhRrD--WUWcfL8ZDw0YZulzPQXcw4oyhwMCi76PdwUwRyOiGVpPkY3i6HcfeFkIquXD0PMlLRUKvLxvBhMJK1Jf71Ra__S_oNPGHBaGPe4QFst3dzd4hYqDVH0fZ_A2-eAXA
  priority: 102
  providerName: Springer Nature
Title Overview of nano-drugs characteristics for clinical application: the journey from the entry to the exit point
URI https://link.springer.com/article/10.1007/s11051-014-2527-7
https://www.proquest.com/docview/1552567608
https://www.proquest.com/docview/1567081172
Volume 16
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwED_BJiQQQlBAFEZlJLQHWDQnseOUF1RQuwnEqNAqlafIjm00aUvKkgL97zk7ST-Q2Eui-COxcmf7znf3O4DXeehcmCIbCInqKkukDlIeiUCZRAuDO27qzQVfzpLTGfs05_P2wK1q3Sq7NdEv1LrM3Rn5sYMK44lIaPp-8TNwWaOcdbVNoXEb9h10mXPpEvO1whUmkU-KHMbIDaivs86q6UPnULBwijQLIjc2sbMv3V_ICn-RbXJb7Aif_9hL_TY0eQgPWvmRjBqCP4JbpujBvS1UwR4cThs46tUROd9EV1VH5JBMN0DVqx7c8e6fefUYrr7-cmuG-U1KSwpZlIG-Xv6oSL4L50xQwiVdLCXZsn2_IyhHEs-XZkVcyIov8FlLSF02D38uarIoL4r6Ccwm4_OPp0GbiCHIGeN1kAxToUNuh8pwphhXQjGt7ZDmVvHUYI3lVvBchEqKOJdK46zm0kYKpQ8UceKnsFeUhXkGhKEGZKSwTHHBqKZDayWPJTWJUKGkug-0I0OWtyjlLlnGZbbBV3aUy5BymaNcJvrwZt1l0UB03NR4sEPbdQ_UHGMWUWxw0BE7a6dzlW2Yrw-v1tU4EZ11RRamXLo2iaAubDfqw9uOSbZe8b8RPb_5gy_gbuS41PscHsBefb00L1EOqtXAMzte08nJAPZHJ98_j_H-YXw2_Yals2j0Fy2ZCgA
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIgQIIVhALJRiJOiBNsLr2HEWCSEELFv6oIet1FuwYxtVgmRpspT9U_xGxs5mH0j01mPiR6J888x4ZgCe5z1_hIm5SCp0V3miTJQKJiNtEyMtatw0hAsODpPhMf98Ik7W4E-bC-OPVbYyMQhqU-b-H_krXypMJDKh6dvxz8h3jfLR1baFRkMWe3Z6ji5b9Wb3A-L7grHBx9H7YTTrKhDlnIs6StDLNj3h-toKrrnQUnNjXJ_mTovU4ogTTopc9rSSca60QRIVyjGNqhT1dYz7XoGrPI77nqPSwad51CJhoQlzL0bqozLhbRQ1pOqhIeMddx4x_y3kih68NVYVQuKaXhorxu4_8dmg9gZ34PbMXiXvGgK7C2u26MDNpSqGHdg6aspfT3fIaJHNVe2QLXK0KIw97cC1cNw0r-7Bjy-_vIyy56R0pFBFGZmzybeK5Kvlowla1KTN3SRLsfbXBO1WEvjATolPkQk3QpcUUpfNxe_TmozL06K-D8eXAtEDWC_Kwj4EwtHjsko6roXk1NC-c0rEitpE6p6ipgu0hSHLZ1XRfXOO79minrNHLkPkMo9cJrvwcr5k3JQEuWjy5gq28xXoqcacUZyw0YKdzcRHlS2IvQvP5sPI-D6aowpbTvycRFKfJsy6sN0SydIW_3ujRxc_8ClcH44O9rP93cO9x3CDeYoN5x03YL0-m9gnaIPVejMQPoGvl81pfwEqU0L3
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFD4aQyAQQlBAK4xhJNgDLJrj2HGLhBBiVBuD0YdN6luwYxtNGklZUkb_Gr-OY6fpBYm97THxJVG-43PJuQG8yGMfwsRcJBWaqzxVJuoJJiNtUyMtStxecBd8OUr3T_inkRitwZ82F8aHVbY8MTBqU-b-H_muLxUmUpnS3q6bhUUM9wbvxj8j30HKe1rbdhoNiRza6QWab9Xbgz3E-iVjg4_HH_ajWYeBKOdc1FGKFreJhetrK7jmQkvNjXF9mjstehZHnHBS5DLWSia50gbJVSjHNIpVlN0J7nsNrstExP6MydHc2ItTFhoyxwlSIpUpbz2qIW0PlRpvxPOI-e8iV2TinbGqEB7X9NVYUXz_8dUGETi4B3dnuit53xDbfVizRQduL1U07MD2sCmFPd0hx4vMrmqHbJPhokj2tAM3QuhpXj2AH19_eX5lL0jpSKGKMjLnk-8VyVdLSRPUrkmbx0mW_O5vCOqwJJwJOyU-XSbcCB1TSF02F79PazIuT4v6IZxcCUSPYL0oC7sBhKP1ZZV0XAvJqaF955RIFLWp1LGipgu0hSHLZxXSfaOOs2xR29kjlyFymUcuk114NV8ybsqDXDZ5awXb-Qq0WhPOKE7YbMHOZqykyhaE34Xn82FkAt6zowpbTvycVFKfMsy68LolkqUt_vdGjy9_4DO4iWcs-3xwdPgEbjFPsCH0cRPW6_OJfYrqWK23At0T-HbVB-0vEThHJA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Overview+of+nano-drugs+characteristics+for+clinical+application%3A+the+journey+from+the+entry+to+the+exit+point&rft.jtitle=Journal+of+nanoparticle+research+%3A+an+interdisciplinary+forum+for+nanoscale+science+and+technology&rft.au=Bose%2C+Tanima&rft.au=Latawiec%2C+Diane&rft.au=Mondal%2C+Partha+Pratim&rft.au=Mandal%2C+Subhra&rft.date=2014-08-01&rft.issn=1388-0764&rft.eissn=1572-896X&rft.volume=16&rft.issue=8&rft.spage=1&rft.epage=25&rft_id=info:doi/10.1007%2Fs11051-014-2527-7&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1388-0764&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1388-0764&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1388-0764&client=summon